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The final stage in the production of infectious retroviral particles is the scission of
membrane tethers connecting nascent virions to the host cell. Efficient retrovirus release
requires late domains, short peptide motifs within the structural Gag proteins that engage
the cellular Class E vacuolar protein sorting (VPS) machinery. Three classes of late
domains have been described in retroviruses, each with its own cellular interaction
partners: PT/SAP domains bind Tsg101, LxxLF or YPXL domains bind ALIX, and PPxY
domains bind Nedd4-like HECT ligases, a class of ubiquitin ligase enzymes. The
functional link between HECT ligases and the VPS pathway has not been defined, but
multiple lines of evidence suggest that ubiquitin is generally important for late domain
activity. Retroviral Gag proteins are often monoubiquitinated, and depletion of free
cellular ubiquitin results in accumulation of assembled but immature virions at the cell
surface, attached to the cell by membranous stalks. Moreover, mutation of multiple
ubiquitin acceptor sites (lysine residues) in HIV-1 and RSV Gag proteins markedly
inhibits budding. However, the precise role of ubiquitin in retroviral particle release is
poorly understood.
To test the importance of direct Gag ubiquitination for viral particle release we
constructed a prototype foamy virus (PFV)-derived Gag protein devoid of lysine residues,
which can assemble at the plasma membrane in the absence of other viral protein
expression. Efficient release of lysine-free PFV Gag virus-like particles (VLPs) required

the PSAP late domain and an intact Class E VPS pathway. Remarkably, the MLV PPXY
late domain could functionally replace the PSAP motif in lysine-free Gag, retaining its
capacity to engage HECT ubiqutin ligases and support particle release. Moreover,
overexpression of catalytically active HECT ligases markedly stimulated PPxYdependent lysine-free PFV Gag budding, while catalytically inactive mutants did not.
Interestingly, the ability of different HECT domains to promote PFV VLP release
correlated with their autoubiquitination activity, but not with their ability to ubiquitinate a
Gag substrate containing late domain-proximal lysine residues.
Importantly, direct fusion of ubiquitin to the C-terminus of lysine free PFV Gag
rescued budding in the absence of conventional late domains. Additionally, ubiquitin
fusion dramatically enhanced PSAP-dependent budding. This effect was observable only
when a large fraction of Gag carried ubiquitin. Ubiquitin-dependent particle production
was abolished by overexpression of dominant negative Vps4 and disruption of the Ile44
hydrophobic patch in ubiquitin. Individual depletion of Tsg101 and ALIX partially
suppressed ubiquitin-dependent budding, and the inhibition was enhanced by
simultaneous depletion of the two factors. Thus, multiple ubiquitin-binding Class E
factors may provide redundant mechanisms for engaging the VPS machinery, which is
essential for ubiquitin-dependent budding.
Our findings suggest that deposition of ubiquitin at sites of virion assembly by
HECT ligases provides docking sites for class E factors, in effect serving as an alternative
or additional late domain. However, since both lysine free and ubiquitin fused versions of
PFV Gag proteins support budding, the precise nature of the ubiquitin acceptor, be it the
Gag protein itself or trans-acting factors, appears unimportant.
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Chapter I. Introduction

Retroviruses comprise a diverse family of RNA viruses that infect virtually all
vertebrates. They are notable for their ability to establish persistent infection by making
DNA copies of their genomes and integrating them into the host’s genomic DNA [1],
using virally encoded reverse transcriptase [2] and integrase enzymes [3-5]. Though most
retroviruses are relatively benign, several members are highly pathogenic and have been
associated with tumorigenesis [6-8] and immune deficiency [9]. An enormous amount of
research in recent decades has been devoted to the study of human immunodeficiency
virus (HIV)-1, the causative agent of AIDS, which has killed over 25 million since its
discovery. However, retroviruses also hold great interest as vectors for delivery of gene
therapy and markers of evolutionary history.
Retroviral particles consist of a membrane-enveloped protein shell that collapses
upon maturation to form a dense spherical, conical, or cylindrical inner core (reviewed in
[10,11]). This core, or capsid, carries essential viral enzymes and two single-stranded
linear copies of the RNA genome, tightly complexed with nucleocapsid proteins. The
phospholipid bilayer that covers the virion is derived from the host cell membrane and
contains highly glycosylated envelope proteins, which protrude from the surface and
determine host cell tropism.

Retrovirus replication cycle
The infectious cycle (illustrated in Fig. 1) begins with the initial attachment of
virions to target cells by interaction with various molecules expressed on the cell surface
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Figure
1.

Figure 1. The retroviral lifecycle. (A) Typical route of cell infection and integration into
host genome. (B) Typical route of virion production, including gene expression,
assembly, and release. Taken from Goff, Nature Reviews Microbiology, 2007 [12].
[13,14]. This concentration of viral particles at the plasma membrane facilitates the
recognition and binding of specific host receptors by the surface-binding region of viral
envelope proteins [15-18]. A series of conformational changes within the transmembrane
region of envelope proteins mediates the fusion of viral and cellular membranes, allowing
the release of the capsid into the cytoplasm (reviewed in [19,20]). Fusion may be
triggered directly by receptor binding at the plasma membrane [21] or by exposure to low
pH in acidified endosomes following internalization [22-24]. Although some DNA
synthesis may begin in the virion [25-27], the majority of reverse transcription in most
retroviruses occurs soon after entry into the host cell and may be triggered by the high
concentration of deoxyribonucleotides in the cytoplasm [28,29]. Upon entry the viral core
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begins a process of progressive disassembly, known as uncoating [29-31]. The preintegration complexes (PICs), consisting of viral cDNA and associated enzymes,
structural and accessory proteins, migrate toward the nucleus by engaging the cellular
actin cytoskeleton and/or microtubule network and associated motor proteins [30,32-34].
In order to access the host cell genome, retroviral PICs must penetrate the nuclear
membrane. Since lentiviruses can infect non-dividing cells [35-38], their PICs
presumably enter the nucleus through the nuclear pore. Several lentiviral proteins and the
viral DNA itself have been reported to possess nuclear targeting elements [39-44];
however, none of them have been unequivocally shown to be absolutely required for PIC
nuclear import [45-48]. Most retroviruses must wait for nuclear envelope breakdown
during mitosis to access the nucleus and thus depend on the cell cycle for productive
infection [37,49,50]. The viral integrase enzyme catalyzes the double transesterification
reaction to insert the viral cDNA into the host genome [51-54]. Although integration site
selection is generally not sequence-specific, it may be influenced by regional chromatin
structure [55,56] and interactions between integrase and chromatin-binding proteins [5760]. Retroviral integration is essentially permanent and allows the viral genome to persist
as a provirus for the lifetime of the cell.
The cellular transcription machinery treats the provirus as a host gene, generating
a capped and polyadenylated viral mRNA (reviewed in [61]). Most proviral promoters,
located within the long terminal repeat (LTR) regions, are constitutively active; however,
some LTR promoters require transactivation by virally encoded regulatory factors [62].
Nuclear export of unspiced or partially spliced viral mRNA requires interaction of
specific RNA structural elements with the host RNA export machinery, either directly or
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through the activity of viral cofactors [63-66]. Simple retroviruses encode only the gag,
pol, and env genes, while complex viruses encode additional regulatory or accessory
genes. The gag gene codes for the structural proteins that drive particle assembly and
make up the viral core [67,68], pol codes for essential enzymatic functions [2-4,69], and
env codes for the envelope glycoproteins that mediate host receptor recognition and
membrane fusion. The Gag structural precursor is translated by free ribosomes from
unspliced RNA. In most retroviruses, one in every 10-20 translation events results in
readthrough [70,71] or frameshifting [72,73] at a slippery sequence before the Gag stop
codon, generating the Gag-Pol polyprotein. Env proteins are translated from singly
spliced subgenomic mRNAs on membrane-bound ribosomes in the endoplasmic
reticulum, where they fold, oligomerize, and become heavily glycosylated. En route to
the plasma membrane, Env traffics through the Golgi, where it gets cleaved by furin-like
proteases to generate surface and transmembrane subunits (reviewed in [12]).
In most retroviruses assembly of extracellular virions is driven primarily by Gag,
and expression of the Gag protein in the host cell is sufficient for the formation and
release of virus-like particles (VLPs) (Fig. 2). The M (membrane binding)-domain of Gag
mediates membrane association through interactions between a patch of hydrophobic and
basic residues near the amino terminus with membrane phospholipids. Fatty acid
(myristate) modifications of some retroviral Gag proteins facilitate membrane targeting
by inserting into the plasma membrane [74-77]. The myristate may be buried in a
hydrophobic pocket of Gag and exposed upon Gag polymerization [78-81]. The I
(interaction)-domain within the C-terminal half of Gag mediates Gag-Gag interactions
that drive particle assembly [82-84]. The L (late budding)-domain, which may be located
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either within the N-terminal third or at the C-terminus of Gag, is essential for efficient
membrane separation between the fully assembled virion and the host cell (reviewed in
[85]). Two major routes of assembly have been observed for different viruses. In some
viruses Gag is targeted directly to the plasma membrane [86,87], where lateral Gag-Gag
interactions and bud growth induce outward membrane curvature. Other viruses preassemble in the cytoplasm before trafficking to the plasma membrane for envelopment
and release [88,89].

Figure 2. Assembly of HIV-1 particles. Gag proteins associate with cellular membranes,
and their oligomerization induces membrane curvature. Viral enzymes are typically
incorporated into virions as part of Gag-Pro-Pol polyproteins, which co-assemble with
Gag. Other viral components are incorporated through interactions with Gag. After
particle release, the viral protease cleaves Gag into MA, CA, and NC and releases the
viral enzymes to generate mature infectious virions. Adapted from Pelchen-Matthews, et.
al. Trends in Microbiology, 2004 [90].
Pol typically gets incorporated into virions as a Gag-Pol polyprotein, which
associates with membranes as it co-assembles with Gag, thereby allowing the virus
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control over the stoichiometry of structural and enzymatic components in the virion. Env
is thought to be incorporated through interactions between its cytoplasmic tail and the Nterminus of Gag [91]. Env may also target Gag to specific membrane domains [92-94].
The viral RNA contains packaging signals near the 5’ end, which mediate its
incorporation into nascent virions by interactions with basic Cis-His sequences in the
nucleocapsid region of Gag [95,96]. The RNA is packaged as a dimer, held together by
base-pairing at specific palindromic sequences, known as dimer linkage structures (DLS)
[97,98].
Formation of mature infections particles requires cleavage of the Gag and GagPol precursors by the viral protease to generate separate matrix (MA), capsid (CA), and
nucleocapsid (NC) structural proteins, and protease (PR), reverse transcriptase (RT), and
integrase (IN) enzymes [69]. NC forms a tight complex with the viral RNA inside the CA
core, while MA remains closely associated with the inner leaflet of the lipid envelope.
Maturation is closely linked to budding, and protease activation may be induced by its
oligomerization during Gag and Gag-Pol co-assembly. However, additional triggers must
occur, since viruses that assemble in the cytoplasm mature only after their release from
the host cell [99].
The membrane fission event that separates nascent virions from the host cell, and
from each other, is not spontaneous. Retroviral Gag proteins and structural proteins of
some other enveloped viruses encode short peptide motifs, called late (L)-domains, which
are essential for efficient virus particle release [100-102]. Inhibition of late domain
function causes fully assembled immature virions to remain tethered to the cell surface by
a continuous membranous stalk (Fig. 3A, B, and C) [100]. Three types of late domains
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Figure 3. Late domains promote efficient separation of fully assembled virions from the
host cell. (A-C) Thin section electron microscopy analysis of (A) MLV with a mutated
PPPY motif [103], (B) MLV in cells overexpressing dominant negative Vps4 E228Q
protein [103], (C) RSV in cells treated with proteasome inhibitor MG-132 [104]. (D)
Examples of late domains from retroviruses, filoviruses (Ebola), and rhabdoviruses
(VSV).
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have been described in retroviruses, containing the PT/SAP [100,101], PPxY [105,106],
or YPxL/LxxLF [107,108] sequence motifs (Fig. 3D). Late budding defects caused by
mutation of these motifs can be rescued by introduction of heterologous late domains.
Moreover, late domains have been shown to retain their activity when transferred to
different positions within Gag, suggesting that they function as docking sites for cellular
factors rather than as essential structural elements [109,110]. Interestingly, several
enveloped viruses encode multiple different late domain motifs in close proximity, with
one usually playing a dominant role in promoting particle release [108,111,112]. Many
aspects of late domain function have been elucidated over the past decade. The cellular
binding partners of retroviral late domains have been described: PT/SAP domains recruit
Tsg101 [103,113,114], LxxLF or YPxL domains recruit AIP-1/ALIX [108], and PPxY
domains recruit Nedd4-like HECT ubiquitin E3 ligases [111,115-121]. All of these late
domains require an intact cellular Class E vacuolar protein sorting (VPS) pathway to
promote virion release [103,108,115,122-124].

Cellular vacuolar protein sorting machinery
The VPS pathway mediates the formation of intralumenal vesicles (ILVs) in
multivesicular bodies (MVBs) (Fig. 4B), a process that involves membrane evagination
away from the cytoplasm and is therefore topologically equivalent to viral budding. The
pathway plays a critical role in the downregulation of activated cell surface receptors
[125,126]. Endocytosed ligand-bound receptors can be either recycled to the plasma
membrane or delivered to the lysosome (vacuole in yeast) for degradation. As late
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Figure 4. Vacuolar protein sorting pathway. (A) Ubiquitinated cell surface receptors are
internalized and delivered to endosomes, which also receive cargoes from the trans-Golgi
network. As endosomes mature, vesicles bud into the lumen to form multivesicular
bodies (MVBs). Some cargoes are recycled back to the plasma membrane, either directly
or indirectly through recycling endosomes. Other cargos are sorted onto intraluminal
vesicles, which eventually get degraded by proteolytic enzymes when multivesicular
bodies fuse with lysosomes. Taken from Nickerson, et. al. EMBO Reports, 2007 [127].
(B) Transmission electron micrograph of a multivesicular body [128]. (C) Aberrant
“Class E” compartment caused by Vps4 deletion in yeast [125].
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endosomes mature, soluble VPS factors are recruited to the limiting membrane, where
they promote the formation and release of vesicles into the endosome lumen and regulate
the sorting of proteins onto ILV membranes. Fusion of mature MVBs with the lysosome
exposes the ILVs and their associated proteins to hydrolytic enzymes, resulting in their
degradation. Proteins on the limiting membrane of MVBs remain intact and may
subsequently get recycled to the cell surface (Fig. 4A). Disruption of the VPS machinery
in yeast results in the formation of abnormally large, multilamellar ‘Class E’
compartments that lack intralumenal vesicles (Fig. 4C) and in the mislocalization of
endocytic cargo proteins to the vacuolar membrane [125].
Ubiquitin modification of endocytic cargo is a key signal for sorting onto
intralumenal vesicles [126]. Ubiquitin is a small (76 residue) polypeptide, highly
conserved among eukaryotes, that becomes covalently attached to other proteins by an
isopeptide bond between the exposed carboxyl group of its C-terminal glycine residue
and the ε-amino group of lysine residues in the substrate protein (reviewed in [129,130]).
Since ubiquitin contains 7 lysine residues (Lys6, Lys11, Lys27, Lys29, Lys33, Lys44,
and Lys63), it can itself serve as a substrate for ubiquitination, thus forming linear or
branched ubiquitin chains [131]. Proteins can be mono- or polyubiquitinated on single or
multiple lysine residues. Few instances of ubiquitin modification on non-lysine residues
have also been reported [132,133]. Different types of ubiquitin modifications are
selectively recognized by various cellular pathways and thus signal different fates for the
substrate protein. Among the numerous functions of ubiquitin, the targeting of misfolded
or damaged proteins for degradation by the 26S proteasome by K48-linked polyubiquitin
chains is the best understood [134]. Lys11-linked ubiquitin chains have recently been
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shown to direct endoplasmic reticulum-associated degradation (ERAD) [135].
Monoubiquitination of membrane receptors appears to be sufficient to signal entry into
the MVB pathway; however, many endosomal cargos are modified by K63-linked or
other types of polyubiquitin chains [126,136-138].
The Class E VPS machinery is highly conserved from yeast to humans, and
genetic studies in yeast have been instrumental to the identification of many mammalian
VPS factors and their interactions. The human vacuolar protein sorting (VPS) machinery
consists of about 30 factors that form several multiprotein complexes, known as
endosomal sorting complexes required for transport (ESCRTs) (outlined in Table 1 and
Fig. 5, reviewed in [139]). The traditional model for ubiquitinated protein sorting
proposes that ESCRT-I, -II, and -III are recruited sequentially to the limiting membrane
of MVBs by their interactions with each other and ubiquitinated cargo. ESCRT-III is
thought to drive the membrane deformation and scission event required for vesicle
budding into the lumen of MVBs [140,141]. The AAA ATPase Vps4 is required for
ESCRT disassembly and VPS factor recycling after each round of vesicle formation and
release [142,143].
ESCRT-I is thought to be responsible for recognition of ubiquitinated cargo and
recruitment of downstream VPS components to endosomal compartments [126]. The
major soluble form of the complex is a heterotetramer of Tsg101 (Vps23 in yeast),
Vps28, Vps37, and MVB12, containing a single copy of each subunit [144,145]. ESCRTI is largely cytosolic, but relocalizes to aberrant endosmoal compartments induced by the
loss of Vps4 activity, either by deletion of the Vps4 gene (in yeast) [126] or
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Figure 5. Late domains recruit HECT ubiquitin ligases or components of the Class E
vacuolar protein sorting (VPS) pathway. Direct protein-protein interactions are indicated
by double ended arrows, and ESCRT-I, -II, and -III complexes are highlighted in yellow,
green, and red, respectively. Adapted from Bieniasz, Virology, 2006 [85]
overexpression of the catalytically inactive Vps4 mutant protein (in mammalian cells)
[146]. Tsg101 can bind ubiquitinated MVB cargo proteins through its ubiquitin E2
variant (UEV) domain, which structurally resembles E2 ubiquitin conjugating enzymes
but lacks a conserved cysteine residue essential for catalytic activity [147,148]. Tsg101
also forms a ternary complex with Vps28 and Vps37 via its C-terminal domain [149].
Vps28, in turn, interacts with ESCRT-II through its C-terminal domain and may thus
mediate its recruitment to membrane domains enriched with MVB cargo [150].
Expression of Tsg101, Vps28, and Vps37 is essential for MVB biogenesis and cargo
sorting [126,146,149]. The recently identified Mvb12 protein interacts with the Tsg101Vps37 binary complex [145] and modulates ESCRT-I function [145,151-153]. The Cterminus of yeast Mvb12 appears to contain a ubiquitin-binding domain [154]. Though
12

Mvb12 is not strictly required for MVB sorting, it appears to prevent premature binding
of ESCRT-I to ESCRT-II and facilitate its dissociation from cargo, thus preventing its
encapsulation within vesicles that bud into the MVB lumen [152]. Mvb12 may also
function in cargo selection, as it appears to enhance ubiquitin-independent cargo sorting
into the yeast vacuole [153].

Table 1. Class E vacuolar protein sorting factors in yeast and mammals
Complex
ESCRT-0

ESCRT-I

ESCRT-II

ESCRT-III

Yeast protein

Mammalian protein

Vps27

Hrs

Hse1

STAM1/2

Vps23

Tsg101

Vps28

Vps28

Vps37

Vps37A/B/C/D

Mvb12

Mvb12A/B

Vps22

Eap30

Vps25

Eap20

Vps36

Eap45

Vps2

CHMP2A/B

Vps20

CHMP6

Vps24

CHMP3

Snf7 (Vps32)

CHMP4A/B/C

Did2 (Vps46) CHMP1A/B

Associated proteins

Vps60

CHMP5

Vps4

Vps4A/B

Bro1

Alix
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Efficient recruitment of ESCRT-I to endosomal compartments appears to require
another complex, sometimes referred to as ESCRT-0, which includes Hrs (Vps27) and
STAM (Hse1) proteins [155,156]. Hrs has been shown to be important for liganddependent lysosomal degradation of platelet-derived growth factor (PDGF) receptor and
epidermal growth factor receptor (EGFR), and its depletion from cells induces the
formation of enlarged endosomes [155]. Hrs contains a FYVE domain, which
preferentially binds PI(3)P-containing membranes, and a coiled-coil domain, which
mediates its association with STAM and contributes to membrane binding [155,157].
Moreover, the central region of Hrs contains a PSAP motif, which is essential for its
interaction with Tsg101 [157-159]. Hrs thus recruits STAM and ESCRT-I to early
endosomal membranes [155,157,158]. The Hrs-STAM complex can directly associate
with ubiquitin via three ubiquitin binding sites in Hrs (one double-sided UIM and one
VHS motif) and two in STAM (one UIM and one VHS) [155,156,160,161]. Mammalian
Hrs also interacts with Eps15, another UIM-containing protein [155]. Mono- and polyubiquitination of membrane proteins serves as a key determinant for their targeting to the
lysosome lumen during the critical sorting step in the MVB. Despite the low affinity of
individual UIMs and VHS motifs for monoubiquitin, multivalent ubiquitin binding by
ESCRT-0 allows it to interact with ubiquitinated cargo with strong avidity [161]. Indeed,
ubiquitinated proteins have been shown to co-localize with Hrs and STAM on endosomal
membrane microdomains [155]. Thus, ESCRT-0 appears to concentrate ubiquitinated
cargo on endosomes while recruiting downstream ESCRT components that mediate
endosome maturation by inducing the formation of intralumenal vesicles.
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ESCRT-II is a stable soluble complex that functions downstream of ESCRT-I
[162]. The complex is a trilobal tetramer, consisting of two copies of EAP20 (Vps25)
bound to single copies of Eap30 (Vps22) and EAP45 (Vps36) [163,164]. Deletion of any
ESCRT-II component in yeast induces the formation of an aberrant Class E compartment
that accumulates endosomal cargo [162]; however, ESCRT-II does not appear to be
universally required cargo sorting in mammals [165]. EAP45 can efficiently bind
phosphoinositide-3-phosphates and can, therefore, independently mediate ESCRT-II
recruitment to endosomal membranes [150,162,166]. Mammalian EAP45 can bind
ubiquitin via its N-terminal GLUE domain [166], and both EAP30 and EAP45 have the
capacity to bind the C-terminal “steadiness box” of Tsg101 [167]. In contrast, the yeast
homolog of EAP45, Vps36, simultaneously mediates ESCRT-II association with
membranes, ubiquitin, and ESCRT-I. The GLUE domain of Vps36 contains two NZF
zinc fingers, one of which binds ubiquitin and the other Vps28 [150]. EAP20 mediates
ESCRT-III recruitment by interacting with the basic N-terminal domain of CHMP6
(Vps20) [150,162,167,168].
ESCRT-III comprises the core machinery of MVB biogenesis that executes the
membrane deformation and scission events required for intralumenal vesicle formation
[140,141,169]. ESCRT-III proteins exist as soluble monomers in the cytosol, held
together in a “closed” autoinhibited conformation by association of their basic amino
terminal portion with the highly acidic carboxy terminal portion [124,170,171]. CHMP6
contains a myristoylation signal that allows it to independently bind endosomal
membranes [170]. Interaction of EAP20 with CHMP6 on endosomes induces a
conformational change in CHMP6, thus activating it to nucleate CHMP4 (Snf7)
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oligomerization [169,171,172]. ESCRT-II, therefore, appears to function as a scaffold for
ESCRT-III assembly. Overexpressed CHMP4 can polymerize in circular membraneassociated filamentous arrays that deform the membrane away from the cytoplasm [140].
Interestingly, ESCRT-II containing a single EAP20 arm can promote CHMP4
oligomerization but cannot support MVB sorting, suggesting that membrane evagination
may require lateral interactions between multiple ESCRT-III filaments [172]. CHMP3
(Vps24) terminates CHMP4 oligomerization and recruits CHMP2 (Vps2), which in turn
recruits Vps4 by interactions with its MIT domain [171]. Incubation of spherical
liposomes with all four yeast ESCRT-III components in vitro induces the formation of
inward invaginations, or buds, which are reversed by addition of Vps4 and ATP. Vps2
(CHMP2) is required for complete detachment of these buds from the limiting
membrane, while Vps4 and ATP are required for subsequent rounds of intralumenal
vesicle formation [141]. Thus, ESCRT-III mediates membrane scission, and Vps4 allows
recycling of ESCRT components.
The mammalian ESCRT pathway appears to have a redundant or alternative
mechanism for ESCRT-III recruitment. AIP1/ALIX binds CHMP4 proteins and contains
a PTAP motif, which mediates its interaction with the Tsg101 UEV domain
[108,122,123]. ALIX thus effectively bridges ESCRT-I with ESCRT-III. Bro1, the yeast
homolog of ALIX, interacts directly with Snf7 but lacks a PTAP-like motif and, therefore
cannot mediate the recruitment of ESCRT-III to ESCRT-I. Instead, it appears to function
as an adaptor for the deubiquitinating enzyme Doa4, whose recruitment to budding
vesicles allows the recycling of ubiquitin from cargo proteins before they become
sequestered within ILVs [173,174]. Similarly, mammalian ESCRT-III components
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recruit deubiquitiniating enzymes AMSH and UBPY to endosomal compartments, where
their catalytic activity is stimulated by interaction with STAM [175].
The Vps4 AAA-type ATPase mediates the dissociation of ESCRT components
from membranes. Recruitment of ATP-bound Vps4 dimers to endosomal membranes is
thought to result in the formation of higher order Vps4 oligomers (hexameric rings) in
association with ESCRT complexes via coiled-coil interactions [176]. Oligomerization
then triggers the ATPase activity of Vps4, inducing a comformational change that
destabilizes the complexes, resulting in ESCRT and Vps4 disassembly and dissociation
from the membrane [142]. The catalytic activity of Vps4 may also be modulated by
interaction with ESCRT-III and other cellular proteins, including LIP5 and Ist1 [177182]. One model for ESCRT disassembly suggests that ESCRT-III proteins associate
with the central pore of the Vps4 ring in the bud neck of nascent vesicles and are shunted
through the pore into the cell interior by conformational changes induced by the ATP
hydrolysis cycle [176,182-184]. The loss of Vps4 catalytic activity causes VPS proteins
to become trapped on endosomal membranes, resulting in profound defects in MVB
biogenesis and cargo sorting [125,142].
The ability of ESCRT-III to induce membrane deformation has been challenged
by a recent study, in which yeast MVB biogenesis was reconstituted in vitro using giant
unilamellar vesicles (GUVs) [185]. Co-assembly of grossly overexpressed ESCRT-III
proteins underneath a membrane into an interior coat can induce membrane curvature and
bud formation [140,141,169]. However, intralumenal vesicles formed by such a
mechanism would, in principle, consume ESCRT components [141] and deliver them to
the lysosome lumen for degradation. At physiological concentrations, ESCRT-III cannot
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induce ILV formation on its own. Instead, ESCRT-I and ESCRT-II together deform GUV
membranes to produce open buds in the absence of cargo or other ESCRT components.
The two complexes localize to the bud neck, and therefore appear to stabilize it, without
entering the bud themselves (Fig. 6B [185]). ESCRT-0 seems to possess an intrinsic
capacity to cluster and concentrate ubiquitinated cargo on membrane patches (Fig. 6A
[155,185]). ESCRT-I recruits ESCRT-0 to the bud neck [157-159], presumably allowing
it to deposit ubiquitin-bearing cargo into the forming intralumenal vesicles (Fig. 6B
[185]). Meanwhile, ESCRT-II recruits ESCRT-III proteins to the bud neck [185],
nucleating the assembly of Snf7 into an interior collar (Fig. 6C [172]) and allowing
membrane scission by Vps2 to release the nascent vesicle into the GUV lumen (Fig. 6D
[141]). While ubiquitinated cargo localizes to intralumenal vesicles, ESCRT components
remain at the bud neck [185], where they can be recycled by Vps4 ATPase activity
[141,169].
Another recent study has challenged the model of sequential handover of
ubiquitinated cargo from ESCRT-0 to ESCRT-I, -II, and -III [154]. Disruption of
ubiquitin binding by either ESCRT-I or ESCRT-II was insufficient to inhibit cargo
sorting to the vacuole in yeast. Simultaneous disruption of ubiquitin binding by both
complexes impaired sorting of some cargos. Complete inhibition of MVB sorting
required disruption of ESCRT-I and ESCRT-II ubiquitin binding and ablation of ESCRTI interaction with ESCRT-0, suggesting that the complexes provide parallel mechanisms
for funneling ubiqitinated cargo into MVB pathway.
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Figure 6. Molecular model for MVB biogenesis. (A) ESCRT-0 self-assembles and
clusters ubiquitinated cargos on endosomal membranes. (B) ESCRT-I and -II deform the
membrane into a bud and stabilize the bud neck. ESCRT-I recruits ESCRT-0, facilitating
deposition of cargo into the bud. (C) ESCRT-II nucleates assembly of ESCRT-III
components in the bud neck into an interior collar. (D) ESCRT-III mediates membrane
scission to release the nascent vesicle into the endosome lumen. ESCRT components
remain on the outside of the limiting membrane until they are recycled by Vps4. Taken
from Wollert and Hurley, Nature, 2010 [185].
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The ESCRT pathway mediates multiple topologically similar membrane scission
events
Recently, the ESCRT pathway has been implicated in mediating the plasma
membrane abscission event of cytokinesis, required for separation of daughter cells from
each other. Tsg101 and ALIX localize to the midbody, a constricted membrane structure
between the daughter cells, and their interaction with Cep55 is essential for the resolution
of the membrane tether [186,187]. Tsg101 binding to ESCRT-I component Vps28 [186]
and ALIX-mediated recruitment of ESCRT-III proteins to the midbody are also important
for cytokinesis [187,188]. Moreover, overexpression of ESCRT-III proteins or
catalytically inactive Vps4 inhibits cytokinesis [186,187,189]. Importantly, the role of
ESCRT proteins in cell division appears to be direct and independent of endosomal
protein sorting, since catalytic activity of Vps4 is required for cytokinesis in archaea, a
separate domain of life that lacks endosomal membranes [190,191].
The Class E VPS machinery executes a membrane fission event common to three
functionally distinct but topologically equivalent processes (Fig. 7). The membrane
deformation activity of ESCRT proteins is commonly thought to be dispensable for viral
budding, since Gag multimerization on membranes appears to have an intrinsic capacity
to induce membrane curvature [192]. However, late domain mutation in some
retroviruses, including Mason-Pfizer monkey virus (MPMV) and murine leukemia virus
(MLV), has been demonstrated to induce early budding defects, manifested by aberrant
or inefficient assembly [110,193,194].
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Figure 7. The ESCRT machinery mediates three topologically similar membrane scission
events: (1) budding of vesicles into the lumen of multivesicular bodies, (2) late domaindependent separation of nascent enveloped virions from the host cell, and (3) abscission
of the plasma membrane between two daughter cells during cytokinesis. Taken from
Wollert, et. al., J. Cell Science, 2009 [195].
As previously mentioned, retroviruses rely on cis-acting elements, called late
domains, within their structural Gag proteins to co-opt the cellular vacuolar protein
sorting pathway. Inhibition of the Class E pathway by expression of dominant negative
Vps4 or ESCRT-III components potently blocks the late stage of virion production by
retroviruses encoding diverse late domains [103,108,113,115,122-124,196]. Viruses
containing YPxL- or LxxLF-type late domains, such as EIAV, engage the Class E
pathway by recruiting ALIX [108], which can in turn recruit the core membrane scission
machinery of ESCRT-III through its direct interaction with CHMP4 proteins [197].
Indeed, the Bro1 domain of ALIX, which mediates this interaction, is essential for its
ability to mediate late domain-dependent budding [196,198]. Viruses encoding PT/SAPtype late domains, including HIV-1, recruit Tsg101 [103,113,114], a core component of
ESCRT-I, which can recruit ESCRT-III indirectly through interactions with ALIX
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[108,122,123,196] or ESCRT-II [123,150,167,168]. Moreover, HIV-1 has been reported
to specifically package Tsg101, Vps28, ALIX, and Vps4 inside virions [108,123]. In
contrast, viruses encoding PPxY-type late domains, such as murine leukemia virus
(MLV) and Rous sarcoma virus (RSV), recruit Nedd4-like HECT ubiquitin E3 ligases,
which have no known binding partners in the Class E pathway [111,115-121].

HECT ubiquitin ligase biochemistry and functions
HECT ligases play an important role in directing the substrate specificity of the
cellular ubiquitylation cascade. Ubiquitin conjugation is a multistep process, involving
the sequential transfer of ubiquitin from an E1 activating enzyme to E2 conjugating
enzymes, then to E3 ligating enzymes, and finally to substrate proteins (reviewed in
[129]). The E1 enzyme initiates the cascade by adenylating the carboxy terminus of
ubiquitin with ATP and then attacking the resulting high-energy anhydride bond with the
sulfhydryl group of its catalytic cysteine to generate an E1-Ub intermediate. The E2
enzyme, in turn, attacks the high-energy thioester bond linking ubiquitin to the E1
enzyme using its own catalytic cysteine, thus transferring the ubiquitin moiety to its own
active site. Finally, the E3 ligase promotes the transfer of ubiquitin from the E2 to a
specific substrate. Eukaryotes express two classes of E3 ubiquitin-protein ligases that
function via distinct mechanisms. RING family E3 ligases lack intrinsic enzymatic
activity and function primarily as scaffolds that position the reactive E2-Ub thioester
bond in close proximity to the nucleophilic amino group of the target lysine residue on
the substrate protein [199]. In addition, RING ligases may trigger conformational
changes in the E2 to stimulate ubiquitin release, thus facilitating its transfer [200]. In
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contrast, the active site of HECT family E3 ligases contains an essential cysteine residue
that forms a direct thioester bond with ubiquitin before catalyzing its transfer to the
substrate [201].
Humans encode 28 known HECT ubiquitin E3 ligases [202], a subset of which
has been grouped into two families based on shared domain organization: the Nedd4
family contains nine members (Fig. 8B), and the HERC family contains six members.
Nedd4-like HECT ligases contain an N-terminal C2 domain, two to four WW domains,
and a C-terminal HECT domain (Fig. 8A). The C2 domain binds phosphoinositides and
mediates ligase recruitment to the plasma membrane and endosomal membranes
[203,204]. The WW domains contain WxxP repeats that bind PPxY motifs in substrate
and adapter proteins [205]. The HECT domain mediates catalysis, using a conserved
cysteine residue near its C-terminus [201,206]. HERC family members contain a catalytic
HECT domain and one or more regulator of chromosome condensation 1 (RCC1)-like
domains (RLDs), which bind chromatin and may possess guanine nucleotide-exchange
factor (GEF) activity [207,208]. The remaining HECT ligases possess various domains in
addition to HECT, including zinc fingers, UBA domains, ankryn repeats, and RING
fingers [209]. HECT ligases perform important regulatory roles in diverse cellular
processes, such as endocytosis, endosomal trafficking, chromatin remodeling, and gene
expression, and their malfunction has been associated with numerous physiological
disorders, including cancers, autoimmunity, hypertension, and developmental defects
(reviewed in [209]).
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Figure 8. Nedd4-like HECT ubiquitin E3 ligases. (A) Typical domain organization of
Nedd4 family members. (B) Phylogenetic tree of the nine human Nedd4-like HECT
ligases. (C) Structure of the HECT domain of WWP1. The N-lobe (blue, residues 546–
802) is connected to the C-lobe (magenta, residues 546-802) by a short flexible hinge
loop (residues 803–806). Taken from Verdecia, Molecular Cell, 2003 [210].
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The catalytic domains of HECT ligases contain two distinct polypeptide lobes
connected by a hinge loop (Fig. 8C). The elongated N-lobe binds E2 enzymes, while the
smaller C-lobe contains the residues critical for catalysis. Hinge loop flexibility is
required for catalytic activity, presumably because the C-lobe must rotate with respect to
the N-lobe, in order to align its catalytic cysteine either with the E2-bound ubiquitin or
with the lysine acceptor residue on the substrate [210]. A highly conserved phenylalanine
residue near the C-terminus of HECT domains is dispensable for thioester bond
formation between ubiquitin and the catalytic cysteine but essential for the subsequent
ubiquitin transfer to the substrate [211,212]. Several HECT domains possess a noncovalent ubiquitin-binding site in the N-lobe, which appears to regulate the length of and,
possibly, linkage types in the synthesized ubiquitin chains. The ubiquitin-interacting site
of mammalian Smurf2 HECT contributes to efficient binding of monoubiquitinated
substrates and is required for polyubiquitination [213]. In contrast, the analogous binding
site in yeast Rsp5 HECT seems to limit ubiquitin chain elongation [214].
Although isolated HECT domains are thought to be constitutively active, HECT
ligases have evolved various mechanisms to regulate their catalytic activity. These
mechanisms limit HECT ligase promiscuity and protect the ligases themselves from
excessive autoubiquitination and consequent degradation. For example, intramolecular
interactions between the C2 and HECT domains of Smurf2 inhibit its activity by
obstructing the catalytic cysteine. Similar autoinhibitory interactions have been observed
in WWP2 and Nedd4 [212]. The Smad7 adapter protein relieves Smurf2 autoinhibition
by displacing the C2 domain from the N-lobe of the HECT domain and further stimulates
catalytic activity by recruiting the UbcH7 E2 enzyme [212,215]. Itch and Nedd4L ligases
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are autoinhibited by intramolecular interactions between their WW and HECT domains
[216,217]. JNK1 kinase relieves Itch autoinhibition by phosphorylating the proline-rich
region of the HECT domain, thereby destabilizing its association with the WW domains
[217]. Autoinhibition of Nedd4L is likely relieved by substrate binding to its WW
domains [216]. Deubiquitinating enzymes can antagonize the activity of some processive
HECT ligases, such as yeast Rsp5, by partially disassembling their ubiquitin chains to
produce mono- and oligo-ubiquitinated substrates [218]. In addition HECT ligase activity
can be both positively and negatively regulated at the substrate recognition level by
adaptors that facilitate or compete with substrate binding to WW domains [219-224].
The yeast HECT ligase Rsp5 has been implicated in mediating both ubiquitindependent and -independent cargo sorting into the MVB pathway. Rsp5 expression is
dispensable for MVB biogenesis, but its deletion is associated with reduction in the
average size of intralumenal vesicles [225]. Direct interaction of the endosomal cargo
protein Sna3 with Rsp5 via an essential PPAY motif is required for its delivery to the
vacuole; however, ubiquitination of Sna3 appears to be dispensable for its sorting [225227]. Remarkably, the catalytic activity of Rsp5 is essential for efficient sorting of lysinefree Sna3, which does not become ubiquitinated [226,227]. Therefore, Rsp5 may promote
MVB sorting of non-ubiquitinated cargo by ubiquitinating either itself or unknown
adaptor proteins.

HECT ligases and ubiquitin in retroviral budding
The catalytic activity of several HECT ubiquitin ligases is essential for their
ability to promote PPxY-dependent virus budding [115,120]. Additionally,
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overexpression of the ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) has
been reported to suppress PPxY-dependent Ebola VLP production by inhibiting the
catalytic activity of Nedd4 [228,229]. Overexpression of catalytically inactive HECT
ligases inhibits PPxY-dependent budding of murine leukemia virus (MLV), MPMV, and
Ebola virus [115,120]. Truncated WWP1, lacking the entire catalytic domain, inhibits
MLV budding more potently than full length WWP1 with a disrupted active site [115],
suggesting that HECT domains may possess activities other than ubiquitin conjugation,
such as cofactor recruitment, that are important for their function in viral budding.
Consistent with this notion, HECT domains localize to membranes of aberrant ‘Class E’
compartments induced by overexpression of catalytically inactive ATPase Vps4 [115].
Since many VPS factors are trapped on Vps4-induced compartments, HECT domains
may be recruited to these membranes by interaction with VPS proteins, either directly or
through unidentified bridging factors. Interestingly, two recent studies have demonstrated
significant stimulation of virion production by HIV-1 Gag lacking known late domains
by overexpression of the HECT ligase Nedd4L. The rescue required the catalytic activity
of Nedd4L, expression of Tsg101, and an intact Class E pathway and was accompanied
by an increase in the ubiquitination of ESCRT-I components [230,231]. However, direct
association between HECT ligases and ESCRT proteins has not been demonstrated.
Multiple lines of evidence suggest a more general role of ubiquitin in retroviral
budding. For example, free ubiquitin is enriched in retrovirus particles [232,233], and low
levels of mono or oligo-ubiquitinated Gag have been detected in HIV-1 virions [234].
Furthermore, proteasome inhibitors block the release of retroviruses that encode PT/SAP
or PPxY late domains, most likely by depleting free ubiquitin from cells
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[104,116,235,236]. Since ubiquitination of cellular proteins can serve as a signal for
MVB sorting by recruiting ESCRT proteins, deposition of ubiquitin on viral structural
proteins may also lead to engagement of the class E machinery. Consistent with this
notion, fusion of ubiquitin to the PTAP-encoding late domain of HIV-1 Gag significantly
enhances its affinity for the Tsg101 UEV domain, despite the inherently weak affinity of
the UEV domain for monoubiquitin alone [103]. Moreover, mutation of multiple
ubiquitin acceptor lysine residues in Gag has been shown to inhibit particle production by
several retroviruses [237,238].
To address whether ubiquitination of viral proteins is generally required for
enveloped viral particle release we took advantage of an unusual retroviral Gag protein
that is almost devoid of lysines. We found that VLP release proceeded efficiently in the
absence of ubiquitin acceptors in the viral protein, when dependent on a motif (PSAP)
that directly recruits the ESCRT machinery. Remarkably, when particle release was
engineered to be dependent on a PPxY motif and a catalytically active ubiquitin ligase,
ubiquitin acceptors in the viral protein remained dispensable. Thus, ubiquitin-dependent
release of enveloped viral particles appears to involve ubiquitin conjugation to transacting factors rather than directly to viral proteins. We also showed that the catalytic
activity of different HECT domains is essential for their ability to promote PPxYdependent VLP release. However, stimulation of budding correlated directly with
autoubiquitination of HECT domains rather than their ability to ubiquitinate Gag.
Moreover, direct fusion of a single ubiquitin moiety to the C-terminus of PFV Gag was
sufficient to promote both late domain-dependent and -independent budding. The ability
of ubiquitin to effectively compensate for the lack of conventional late domain function
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required the Ile44 hydrophobic patch of ubiquitin and an intact cellular VPS pathway.
Our results support a model for HECT ligase-mediated viral budding, whereby the
stimulation of protein ubiquitination in the vicinity of VLP assembly promotes the
concentration of ubiquitin-interacting Class E proteins and consequent recruitment of the
ESCRT machinery to nascent virions.
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Chapter II. Materials and Methods

Construction of membrane-targeted PFV Gag expression plasmids
The PFVΔEnv proviral plasmid and the PFV Env expression plasmid have been
described previously, and were a gift from A. Rethwilm [239]. The wild-type and mutant
(PSAP284-287AAAT) PFV Gag open reading frames were amplified from corresponding
proviral PFV plasmids, that have been previously described [240], using primers directed
to the 5’ and 3’ termini of the PFV Gag coding sequence and appended with NcoI and
XhoI restriction enzyme sites, respectively. These amplicons were inserted into an
NcoI/XhoI digested pCAGGS expression vector, to generate pCAGGS/Gag and
pCAGGS/Gag(PTAP-) respectively. Membrane targeted Gag expression plasmids were
derived from pCAGGS/Gag by inserting annealed oligonucleotides encoding the peptides
MyrR (MGARASGSGRRRGSGRRR), Fyn (MGCVQCKDKE), FynR
(MGCVQCRDRE), and Lck (MGCGCSSHPE) into the NcoI site at the 5’ end of PFV
Gag. Lysine-free PFV Gag proteins were generated by Lys396 to Arg by PCR based
mutagenesis. The pCAGGS/Gag(ASAP) expression plasmid was derived from
pCAGGS/Gag by PCR based mutagenesis. pCAGGS plasmids expressing Lck-Gag-PY,
Lck-Gag-PY-3K, or Lck-Gag-PSAP-PY were constructed by inserting the MLV late
domain with or without three appended lysine residues (LLTEDPPPYRD [KKK]) at the
3’ end of Lck-Gag(K396R) using long PCR primers directed to the C-terminus of Gag.
Plasmids expressing cyan-fluorescent fusions of PFV Gag proteins were constructed by
inserting cerulean fluorescent protein encoding sequence into the 3’ XhoI site of all
pCAGGS/PFVGag derivatives. pCAGGS/Gag-UbΔGG expression plasmids were
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generated by overlap PCR, using pCAGGs/Gag(PSAP), pCAGGS/Gag(PSAP-), and
pCAGGS/Gag(PSAP-PY) as templates for the N-terminal portions and pHA-ubiquitin as
the template for the C-terminal portion. The K48R, K63R, F4A, L8A, I44A, and
QE62,64AA point mutations were introduced into Lck-PFV Gag-PSAP-Ub and Lck-PFV
Gag-ΔPSAP-Ub constructs by PCR-based mutagenesis. Each cDNA was cloned into
pCAGGs for expression in mammalian cells.

Construction of chimeric HECT ligase expression plasmids
Plasmids expressing WWP1, WWP2, Nedd4, Nedd4L, Itch, Smurf1, and Rsp5 have been
described previously [115,225]. The Bul2 HECT domain (encoding residues 1189-1572)
was PCR amplified from 293T cell cDNA. Chimeric HECT ligases containing the C2 and
WW domains of WWP1 and heterologous HECT domains were constructed by overlap
PCR and cloned into the pCR3.1/YFP expression vector, fused to the C-terminus of YFP,
as outlined in Table 2. Plasmids expressing catalytically inactive WWP1 (C890S) and
Rsp5 (C777S) have been described previously [115,225], and Rsp5 (C777S) was used as
a template to generate the catalytically inactive WWP1/Rsp5 expression plasmid.
Plasmids expressing catalytically inactive chimeric ligases were generated by introducing
the following point mutations into wild type chimeric ligases by PCR mutagenesis:
WWP2 C838S, Nedd4 C867S, Nedd4L C922S, Itch C830S, Smurf1 C725S, Bul2
C1540S.
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Table 2. Chimeric HECT ligase construction.

Construct
WWP1/WWP2
WWP1/Nedd4
WWP1/Nedd4L
WWP1/Itch
WWP1/Smurf1
WWP1/Bul2
WWP1/Rsp5

N-

C-

fragment

fragment

Junction primers

WWP1

WWP2

GGTGGTCCACAAATTGCTTATGACCGCAGTTTTCGGTGGAAG

1-542

491-870

CCGAAAACTGCGGTCATAAGCAATTTGTGGACCACCTTTAG

WWP1

Nedd4

GGTGGTCCACAAATTGCTTACTCCAGGGATTACAAAAGAAAG

1-542

520-902

CTTTTGTAATCCCTGGAGTAAGCAATTTGTGGACCACCTTTAG

WWP1

Nedd4L

GGTGGTCCACAAATTGCTTACTCCAGAGAATTTAAGCAGAAATATG

1-542

593-975

CTTAAATTCTCTGGAGTAAGCAATTTGTGGACCACCTTTAG

WWP1

Itch

GGTGGTCCACAAATTGCTTATGTTCGGGACTTCAAAGCAAAG

1-542

483-862

CTTTGAAGTCCCGAACATAAGCAATTTGTGGACCACCTTTAG

WWP1

Smurf1

GGTGGTCCACAAATTGCTTACGAAAGAGATCTAGTCCAGAAG

1-542

374-757

GACTAGATCTCTTTCGTAAGCAATTTGTGGACCACCTTTAG

WWP1

Bul2

GGTGGTCCACAAATTGCTTACAAGCGGGATTTCGAAGCC

1-542

1189-1572

CTTCGAAATCCCGCTTGTAAGCAATTTGTGGACCACCTTTAG

WWP1

Rsp5

GGTGGTCCACAAATTGCTTACAAGCGTGACTTCAGACGTAAG

1-542

431-809

GTCTGAAGTCACGCTTGTAAGCAATTTGTGGACCACCTTTAG

Cloning sites
EcoRI/NotI
EcoRI
EcoRI/NotI
EcoRI/NotI
EcoRI/NotI
XhoI/NotI
EcoRI/XhoI

Construction of chimeric Tsg101/HECT expression plasmids
The Tsg101 expression plasmid has been described previously [113,241]. Tsg-HECT and
WWP1-TsgΔUEV chimeras were generated by overlap PCR, using full length Tsg101,
WWP1, Nedd4L, and Itch as templates, as outlined in Table 3. The amplicons were then
cloned into EcoRI/NotI-digested pCR3.1/YFP expression plasmids, fused to the Cterminus of YFP. Point mutations to inactivate the catalytic domain of each Tsg-HECT
construct (described above) were introduced by PCR-based mutagenesis.
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Table 3. Construction of Tsg101/HECT chimeras

Construct
Tsg-WWP1
Tsg-Nedd4L
Tsg-Itch
WWP1-TsgΔUEV

N-

C-

fragment

fragment

Junction primers

Tsg101

WWP1

CCGCCATACCAGGCAACGTATGAACGCGGCTTTAGGTGGAAGC

1-157

543-922

CCTAAAGCCGCGTTCATACGTTGCCTGGTATGGCGGATAGG

Tsg101

Nedd4L

CCGCCATACCAGGCAACGTACTCCAGAGAATTTAAGCAGAAATATG

1-157

593-975

CTTAAATTCTCTGGAGTACGTTGCCTGGTATGGCGGATAGG

Tsg101

Itch

CCGCCATACCAGGCAACGTATGTTCGGGACTTCAAAGCAAAG

1-157

483-862

CTTTGAAGTCCCGAACATACGTTGCCTGGTATGGCGGATAGG

WWP1

Tsg101

GGTGGTCCACAAATTGCTGGGCCACCAAATACTTCCTACATGC

1-542

157-390

GGAAGTATTTGGTGGCCCAGCAATTTGTGGACCACCTTTAG

Additional expression plasmids
The HIV-1 HXB ΔPTAP proviral plasmid has been described previously [113]. Yeast
two-hybrid plasmids encoding wild type and I44A ubiquitin were constructed by PCR
amplification of ubiquitinΔGG from the pHA-ubiquitin plasmid using 5’ and 3’ primers
appended with EcoRI restriction sites and cloning into the pGBKT7 (Clontech) and
pVP16 vectors [113]. The Class E factor yeast two-hybrid library, encoding a panel of
Class E VPS factors in pGBKT7 and pVP16 backgrounds, has been described [122].
pCR3.1-based expression plasmids encoding fluorescent fusions of WWP1ΔHECT, Vps4
E228Q, Tsg101UEV, Hrs, ALIX, UBPY, and Eap45 have been described previously
[113,115,122,241]. The following mutants, impaired for ubiquitin binding, were
generated by PCR mutagenesis: Tsg101UEV N45A, Hrs LA265,266AL, and Eap45
VFE67,68,70AAA.
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Cell lines and transfections
293T and HeLa cell lines were cultured in DMEM supplemented with 10% fetal bovine
serum and 10µg/ml gentamycin (Gibco). For 293T cell transfections, plasmids were
mixed in 100µl serum-free DMEM, followed by addition of 4µg PEI (Polyethylenimine;
Polysciences) per 1µg total DNA (from a 1mg/ml PEI stock solution). This mixture was
vortexed briefly and incubated at room temperature for 15 minutes before addition to
cells. Transfections were allowed to proceed for 4 hours before replacing with fresh
media. For HeLa cell transfections, plasmids were mixed in 100µl serum-free DMEM
and vortexed briefly. A master mix containing 100µl serum-free DMEM and 5µl
Lipofectamine 2000 (Invitrogen) per reaction was prepared, mixed gently by pipetting,
and incubated at room temperature for 5 minutes. The Lipofectamine 2000 mixture
(105µl) was then added to the plasmid mixture and incubated at room temperature for 15
minutes before addition to cells. Transfections were allowed to proceed for 4 hours
before replacing with fresh media.

Western Blot Analysis
Virion and cell lysates and immunoprecipitates were separated on polyacrylamide gels,
transferred to nitrocellulose membranes, and probed with various antibodies: anti-PFV
human serum, anti-HIV-1 p24CA (183-H12-5C), anti-EIAV equine serum (VMRD, Inc.),
anti-GFP (Roche), and anti-HA (HA.11, Covance). Subsequently, the blots were probed
with species-specific peroxidase-conjugated secondary antibodies and chemiluminescent
substrate reagents (Pierce) for conventional Western blotting. Alternatively, membranes
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were probed with species-specific antibodies conjugated to IRDye800CW, and
fluorescent signals were detected and quantified using a LICOR Odyssey scanner.

Virus particle release assay
PFV Gag VLP release assays were performed either in 100mm plate or 6-well
plate formats. In 100mm plates, 293T cells were seeded at 3 × 106 cells per plate and
transfected the following day with 2µg pCAGGS/Gag plasmids, alone or with 4µg
pCR3.1/YFP, pCR3.1/YFP-WWP1, or a derivative. Virus-like particles were pelleted by
ultracentrifugation of 8ml 0.22-µm-filtered culture supernatants, collected 24 hours posttransfection, over a 4ml 20% sucrose cushion for 2 hours at 100,000 × g. In 6-well plates,
293T cells were seeded at 5 × 105 293T cells per well and transfected the following day
with 1µg of pCAGGs/PFVGag-derived plasmids, alone or with 1µg of pCR3.1/YFP,
pCR3.1/YFP-WWP1-HECT, pCR3.1/YFP-TsgUEV-HECT, or pCR3.1/YFP-WWP1TsgΔUEV plasmids. Alternatively cells were transfected with 1µg of pCAGGs/PFVGagderived plasmids and the indicated amounts of fluorescent Class E factor expression
plasmids. Virus-like particles were pelleted by ultracentrifugation of 2ml 0.22-µmfiltered culture supernatants, collected 48 hours post-transfection, over a 2ml 20%
sucrose cushion for 90 min at 115,000 × g.
HIV-1 and EIAV VLP release assays were performed in 6-well plates. 293T cells
were seeded at 5 × 105 293T cells per well and transfected with 500ng of pCR3.1/HIV1Gag or pCR3.1/EIAVGag expression plasmids or HIV-1 HXB-ΔPSAP proviral plasmid
and the indicated amounts of fluorescent Class E factor expression plasmids. VLPs were
pelleted by ultracentrifugation of 2ml of 0.22-µm-filtered culture supernatants, collected
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48 hours after transfection, over a 2-ml 20% sucrose cushion for 90 min at 115,000 × g.
VLP and cell lysates were analyzed by conventional or quantitative Western blotting.

Ubiquitin transfer assay
293T cells (5 × 105) in six-well plates were cotransfected with 1 µg of
pCAGGs/PFVGag-PY-3K, 500 ng of pHA-ubiquitin, and 1 µg of the indicated chimeric
pCR3.1-WWP1-HECT ligases. At 36 hours after transfection, each well of cells was
thoroughly lysed at room temperature with 400µl of denaturing lysis buffer (50mM Tris
pH 7.4, 150mM NaCl, 1mM EDTA, 1.0% glycerol, 0.5% SDS, supplemented with
protease inhibitor tablets (Roche) and 5mM N-ethylmaleimide to inhibit
deubiquitination), sonicated, and cleared of cellular debris by microcentrifugation at
14,000 rpm for 10min. The lysates were then diluted 5-fold, to adjust the concentration of
SDS to 0.1% and NP-40 to 1.0%, and split into two fractions. From one fraction, Gag
proteins were immunoprecipitated with αPFV serum and protein G-Sepharose beads.
From the other fraction, YFP-HECT ligase proteins were immunoprecipitated with αGFP
monoclonal antibody and protein G-Sepharose beads. The beads were washed three times
with RIPA buffer (50mM Tris pH 7.4, 150mM NaCl, 1mM EDTA, 0.1% SDS and 1.0%
NP-40), and proteins were eluted from the beads by boiling for 10 minutes in 2x SDS
protein sample buffer, supplemented with 2% 2-mercaptoethanol. Immunoprecipitates
and unfractionated cell lysates were then analyzed by conventional chemiluminescent or
quantitative fluorescent Western blotting.
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Fluorescence microscopy
HeLa cells (4 × 105) on 35-mm poly-D-lysine coated glass bottom dishes (Mattek) were
cotransfected with plasmids expressing CFP-fused and unfused Lck-Gag at a 1:1 ratio,
either alone or along with 200 ng pCR3.1/YFP-WWP1-WW. Twenty-four hours post
transfection cells were fixed in paraformaldehyde and visualized by deconvolution
microscopy using an Olympus IX70-based DeltaVision system (Applied Precision)
equipped with a 100× magnification oil immersion objective and a Photometrics CH350L
camera. Optical filters were used to distinguish YFP and CFP fluorophores. For each
condition, a stack of 30 images spaced by 0.3µm in the Z-dimension was acquired and
deconvolved using SoftWorx software (Applied Precision), and single optical sections at
the center of the cell and at the cell-coverslip interface were selected.

Electron microscopy
Electron micrographs of assembling Lck-PFV virus-like particles were generated by
Marc C. Johnson (Department of Molecular Microbiology and Immunology, University
of Missouri). Briefly, DF-1 cells were transfected with plasmids expressing GFP-VPS4
(E228K) along with Lck-Gag, or MLV GagPol along with pdsRED, and fixed in
paraformaldehyde. After fluorescence imaging, cells were fixed in glutaraldehyde,
postfixed in osmium tetroxide, dehydrated in ethanol, critical point-dried, and sputtercoated with gold palladium. Cells were identified by their location on a finder grid and
imaged by using a LEO 1550 field-emission scanning electron microscope.
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Yeast two-hybrid assay
Yeast cells (Y190) were transformed with 1µg each of the pGBKT7- and pVP16-derived
plasmids described above. Cells transformed with pGBKT7 plasmids expressing each
class E factor were co-transformed with either empty pVP16 vector, pVP16-Ub or
pVP16-Ub(I44A). Alternatively, cells transformed with pVP16 plasmids expressing each
class E factor were co-transformed with either empty pGBKT7 vector, PGBKT7-Ub, or
pGBKT7-Ub(I44A). Double transformants were selected on supplemented agar plates
lacking leucine and tryptophan. After two days, yeast pellets consisting of 10-20 colonies
were resuspended in 0.5ml Z-buffer (60mM Na2HPO4, 40mM NaH2PO4, 10mM KCl,
1mM MgSO4, 0.28% 2-mercaptoethanol, 0.01% SDS) and permeabilized by addition of
25µl chloroform and vortexing. Protein-protein interactions were assayed by βgalactosidase reporter activity. The β-galactosidase substrate chlorophenol red-β-Dgalactopyranoside (CPRG, Roche) was added to a final concentration of 1.4mg/ml, and
the suspensions were mixed by vortexing and incubated at room temperature for 30
minutes. The optical density of the supernatants at 540nm was measured after pelleting
the cell debris by microcentrifugation,

RNA interference
293T cells were transfected in 6-well plates using a modified Lipofectamine 2000
protocol. Cells were seeded at 3 × 105 cells per well in DMEM supplemented with 10%
fetal bovine serum containing no antibiotics and transfected the following day with
siGENOME siRNAs targeting Luciferase, Tsg101, Hrs, Alix, UBPY, or Eap45
(Dharmacon). For single siRNA transfections, 40pmol siRNA was combined with 200ml
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serum-free OptiMEM and a master mix consisting of 6µl Lipofectamine 2000 and 200µl
OptiMEM per reaction was prepared. After incubating both mixtures at room temperature
for 15 minutes, 206µl of the Lipofectamine 2000 mixture was added to each siRNA
mixture and mixed gently by pipetting. After another 15-minute incubation at room
temperature, the reactions were added to cells. Transfections were allowed to proceed for
4 hours before replacing with fresh media. After 24 hours, cells were transfected again
with the same siRNAs and the indicated Gag expression plasmids. VLP and cell lysates
were prepared 48 hours after the second transfection. For combination knockdown
experiments, 293T cells were transfected with 40 pmol of each siRNA, and the total
amounts of siRNA tranfected were maintained at 80 pmol per reaction. To assess
knockdown efficiency, 293T cells were transfected once with YFP-Tsg101, -Hrs, -ALIX,
-UBPY, or -Eap45 expression plasmids and corresponding siRNAs. GFP expression in
cell lysates harvested 48 hours after transfection was assayed by quantitative Western
blotting.
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Chapter III. Direct viral protein ubiquitination is dispensable
for ubiquitin ligase-dependent virus particle budding

The Gag proteins of several retroviruses carry low levels of ubiquitin
[232,233,234], and the extent of ubiquitinaton appears to depend on the type of late
domain they encode [112]. However, the functional relevance of direct Gag
ubiquitination is disputed. On the one hand, mutation of multiple lysine residues in Gag
blocks the late phase of HIV-1 and RSV budding at the plasma membrane without
significantly affecting particle morphology [237,238]. On the other hand, budding
efficiency does not necessarily correlate with the extent of Gag ubiquitination, as
transplantation of PPxY late domains into late domain-deficient HIV-1 Gag leads to an
increase in Gag ubiquitination but fails to rescue particle production [112]. Additionally,
the inhibition of HIV-1 and RSV budding by extensive mutagenesis of Gag lysines may
result from disruption of structural elements important for the late stage of particle
release rather than the loss of ubiquitin acceptor sites. We noticed that the Gag proteins of
the Spumaviruses (or Foamy viruses) are remarkably lysine-poor. This is an extremely
unusual property, shared by all known members of the spumavirus subfamily (Table 4),
to test whether ubiquitination of viral proteins is essential for the activity of late domains.

Table 4. Abundance of basic residues in retroviral Gag proteins.
Viral Gag

HIV-1

MLV

RSV

MPMV

PFV

SFV-1

SFVcpz

SFVora

FeFV

BFV

EqFV

Lys

38

31

30

58

1

0

2

1

8

0

1

Arg

28

50

48

22

64

56

61

60

46

48

50
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Spumaviruses comprise a unique subfamily of retroviruses (Fig. 9) with several
distinguishing characteristics (reviewed in [242,243]). Prototype foamy virus (PFV)
utilizes a dual promoter system for transcription. The internal promoter, which drives the
expression of Tas and Bet accessory genes, exhibits higher basal activity than the LTR
promoter. Tas encodes the viral transactivator protein, which enhances transcription from
both the LTR and the internal promoter. Unlike orthoretroviruses, which express Pol as
part of a Gag-Pol polyprotein, PFV expresses Pol from a separately spliced mRNA. The
precise mechanism of Pol incorporation into virions is unclear but appears to require Pol
interaction with Gag, either direct or through co-association of both proteins with the
viral genomic RNA [244,245]. PFV Gag lacks the canonical Cys-His boxes required for
RNA binding of orthoretroviral NC proteins. Instead, three glycine- and arginine-rich
repeat regions (GR boxes) mediate Gag interaction with nucleic acids (both RNA and
DNA) and nuclear import. Although the viral genome is packaged as RNA, reverse
transcription occurs late in the viral lifecycle, before or during budding [246]. Therefore,
the major form of infectious nucleic acid in the PFV virions appears to be DNA [247].

Figure 9. Phylogenetic tree of
retroviral pol sequences. The tree
was derived by alignment of
ungapped portions of Pol protein
sequences. Taken from [243].
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The Gag protein of Foamy viruses does not undergo conventional processing into
mature matrix (MA), capsid (CA), and nucleocapsid (NC) products. Instead the fulllength 72-kDa precursor is cleaved near its C-terminus into 68- and 4-kDa products, and
the two high molecular weight proteins are detected in virions at approximately
equimolar amounts [248]. PFV encodes PT/SAP as its primary L-domain (Fig. 10A),
which induces viral particle release by binding to the Tsg101 component of ESCRT-I
[240,249]. While PFV Gag only contains a single lysine (residue 396, Fig. 10A), there
are potential ways in which the near-absence of lysine acceptors in FV Gag proteins
could be circumvented while maintaining a requirement for viral protein ubiquitination in
particle release. For example, unlike many retroviral Gag proteins, the N-terminus of
PFV Gag is not myristoylated and could serve as a putative ubiquitin acceptor site.
Additionally, FV Pol proteins do not exhibit the striking lysine-poor sequence bias of
Gag and provide numerous opportunities for virion protein ubiquitination. Finally, FVs
are unusual among retroviruses in that they pre-assemble complete capsids in the
cytoplasm of infected cells and bud preferentially at intracytoplasmic membranes into
vesicles, which are thought to be subsequently transported to the cell surface [250,251].
The leader peptide of the cognate Env protein is required to direct FV capsids to
membranes for envelopment and release [248,252]. Notably, the cytoplasmic portion of
the PFV Env leader peptide contains five lysine residues, which are extensively
ubiquitinated [253]. Thus, virion proteins other than Gag could substitute for the
presumed role of Gag ubiquitination in virion release. Therefore, we first derived an
experimental system in which extracellular PFV VLPs were generated by Gag in the
absence of other viral proteins.
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Figure 10. Envelope-independent release of VLPs generated by membrane-targeted PFV
Gag proteins. (A) Schematic representation of the PFV Gag protein, indicating relevant
landmarks [the PSAP late domain, a single lysine residue, glycine/arginine (G-R)-rich
domains, and a proteolytic cleavage site near the C-terminus of the ~72-kDa protein].
Also shown are the various membrane-targeting peptides that were appended to the PFV
Gag N terminus. (B) Virion production by 293T cells transfected with the PFVΔEnv
proviral plasmid, either alone or along with a PFV Env expression vector. Virion and cell
lysates were analyzed by Western blotting with αPFV human serum. (C) VLP production
by 293T cells transfected with plasmids expressing PFV Gag appended with the indicated
membrane-targeting signals.
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Generation of PFV Gag virus-like particles in the absence of other virion proteins
Previous work, using the Src oncoprotein myristoylation signal, has shown that
appending the amino terminus of PFV Gag with a membrane-targeting signal can bypass
the requirement for Env coexpression in particle release [251]. However, like the Src
signal, most peripheral membrane-targeting signals contain lysine residues, complicating
the interpretation of experiments that test the functional role of Gag ubiquitin acceptors.
Therefore, we designed PFV Gag proteins appended with candidate lysine-free plasma
membrane-targeting peptides. These consisted of the following: (i) an artificial
membrane targeting peptide (MyrR), comprising the minimal six-residue myristoylation
signal of HIV-1 Gag followed by an arginine-rich linker; (ii) a ten-amino-acid
myristylated and palmitoylated peptide derived from the N-terminus of the Fyn
oncoprotein, in which two lysines were mutated to arginine (FynR); and (iii) a naturally
lysine-free ten-amino-acid myristoylated and palmitoylated peptide from the N-terminus
of the Lck oncoprotein (Fig. 10A). Control experiments confirmed that the authentic PFV
Gag protein, expressed from a PFV proviral plasmid, was released in extracellular
particles only when Env was coexpressed (Fig. 10B). Concordantly, expression of the
PFV Gag protein in the absence of any other viral protein did not generate VLPs (Fig.
10C). However, the membrane-targeted Gag proteins formed extracellular particles in the
absence of Env expression. In the case of MyrR-Gag, VLP formation was inefficient, but
the myristylated/palmitoylated Gag proteins (Fyn-Gag, FynR-Gag and Lck-Gag)
efficiently generated extracellular VLPs (Fig. 10C). Since Lck-Gag formed VLPs with
marginally greater efficiency than FynR-Gag, without introducing lysine residues, it was
selected for further experiments.
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Lck-Gag targets the plasma membrane and requires its PSAP motif to form
extracellular VLPs
We next verified that our targeting strategy had the intended consequences. An
Lck-Gag-CFP fusion protein efficiently targeted the plasma membrane in HeLa cells
(Fig. 11A). Indeed, like most retroviral Gag-GFP fusion proteins, Lck-Gag-CFP was
visible as fluorescent puncta at the cell surface, particularly when the cell surfacecoverslip interface was imaged. To confirm that Lck-Gag assembled into VLPs, it was
expressed in HeLa and DF1 cells, which have unusually smooth surfaces, facilitating the
detection of surface VLPs using scanning electron microscopy. Although we sometimes
observed short filamentous particles on the surface of Lck-Gag-expressing HeLa or DF1
cells, it was often difficult to observe retroviral VLPs by this technique, unless their
release was arrested by coexpressing a dominant negative version of Vps4 [Vps4
(E228Q)]. We observed numerous short filamentous particles extending from the surface
of DF1 cells coexpressing Lck-Gag and Vps4 (E228Q) (Fig. 11B). While these differed
from the spherical cytoplasmic particles that were assembled by non-membrane targeted
PFV Gag, they were indistinguishable from those assembled by MLV Gag, which have
been shown to be filamentous in the absence of co-expressed glycosylated Gag [254] or
when L-domain function was inhibited [110,115].
As additional verification of the authenticity of Lck-Gag assembly, we
determined whether VLP release required an intact L-domain. Indeed, both the
membrane targeting signal and the PSAP motif in Lck-Gag were required for VLP
release (Fig. 11C). Thus, Lck-Gag mimics a conventional retroviral Gag protein in that it
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assembles and is released at the cell surface via a plasma membrane-targeting signal and
late domain-dependent engagement of the class E VPS machinery.

Figure 11. Lck-Gag forms VLPs at the plasma
membrane that are released in a late domain-dependent
manner. (A) HeLa cells expressing Lck-Gag-CFP
(green) were fixed, and nuclei were stained with
Hoechst (blue). Single deconvolved optical sections
acquired at the center of the vertical dimension of the
cell (Upper) or at the cell-coverslip interface (Lower)
are shown. (B) Scanning electron micrograph of DF1
cells transfected with Lck-Gag and GFP-VPS4(E228Q).
Representative transfected (black arrow) and
untransfected (white arrow) cells, identified by GFP
expression, are shown (Left). A higher-magnification
view of area indicated by the dashed box is also shown
(Right). (C) VLP production by 293T cells expressing
wild-type PFV Gag or Lck-Gag proteins encoding
either wild-type or mutant (PSAP284–287 mutated to
AAAT) late domains.
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Class E VPS machinery- and ubiquitin ligase-dependent budding of lysine-free
Gag
Next, we constructed Gag proteins devoid of ubiquitin acceptors by replacing the
single lysine in Lck-Gag and Lck-Gag(PSAP-) with arginine (Fig. 12A). Because the
amino terminus of Lck-Gag is occupied by myristoylation, this manipulation should
remove all potential ubiquitin acceptor sites from Lck-Gag. Remarkably, the LckGag(K396R) protein efficiently generated extracellular VLPs (Fig. 12B), and this was
dependent on engagement of the class E VPS machinery, because LckGag(K396R)(PSAP-) failed to generated extracellular VLPs (Fig. 12B). Notably, the
efficiency with which Lck-Gag and Lck-Gag(K396R) formed VLPs was
indistinguishable, strongly suggesting that viral protein ubiquitination is dispensable for
the function of PT/SAP late domains.
Because P(T/S)AP-type late domains directly bind to Tsg101 to recruit the class E
VPS machinery, they could conceivably bypass the requirement for ubiquitination and
thereby supplant the perceived role of ubiquitin in viral budding. Therefore, we next
determined whether Gag ubiquitination is required for the function of a late domain that
acts via ubiquitin ligase recruitment. To this end, we appended a murine leukemia virus
(MLV)-derived late domain to the C-terminus of Lck-Gag(K369R) in which the PSAP
motif had been inactivated, generating Lck-Gag-PY (Fig. 12C). PPxY motifs recruit
HECT ubiquitin ligases by binding their WW domains; therefore, to verify that the
transplanted MLV-derived late domain could indeed recruit a ubiquitin ligase that can
induce MLV budding (WWP1) [115], Lck-Gag-PY-CFP was coexpressed with YFP
fused to the WW domains of WWP1 (YFP-WW). The YFP-WW fusion protein
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Figure 12. PT/SAP and PPxY-type late domains induce budding of lysine-free Gag
proteins. (A) Schematic representation of lysine-free Lck-Gag proteins. (B) Western blot
(αPFV) analysis of Lck-Gag expression in and VLP release from 293T cells transfected
with Lck-Gag(K396R) expression plasmids encoding either the wild-type or mutant late
domains. (C) Schematic representation of the Lck-Gag-PY protein, which is lysine free
and encodes an MLV-derived late domain, appended at its C terminus. (D) YFP-WW
fusion protein localization in HeLa cells coexpressing lysine-free Lck-Gag-CFP proteins
encoding a PSAP motif, no late domain, or the MLV late domain, as indicated. (E)
Western blot analysis (αPFV) of VLP production by 293T cells expressing lysine-free
Lck-Gag proteins encoding the indicated late domains. (F) Western blot analysis (αPFV)
(Top and Middle) of VLP production by 293T cells expressing Lck-Gag-PY. Cells were
cotransfected with the indicated amounts of a YFP-VPS4(E228Q) plasmid, the
expression of which was monitored by using αGFP Western blotting (Bottom).
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constitutively localizes to the nucleus but is relocalized, in a PPxY dependent manner,
when coexpressed with MLV Gag or Ebola virus matrix [115]. Notably, YFP-WW was
efficiently recruited to the plasma membrane in cells coexpressing Lck-Gag-PY-CFP, but
remained in the nucleus of cells expressing Lck-Gag proteins lacking the MLV late
domain (Fig. 12D). Thus, the MLV PPxY motif was capable of recruiting WWP1 in the
context of Lck-Gag-PY.
Remarkably, The PPxY late domain stimulated the budding of lysine-free LckGag (Fig. 12E), albeit less efficiently than the natural PSAP late domain (Fig. 12E).
Moreover, Lck-Gag-PY particle release was inhibited by Vps4 (E228Q) overexpression,
indicating that the requirement for a functional class E VPS pathway in PPxY-dependent
budding of PFV Gag was maintained (Fig. 12F). Thus, a late domain that functions by
recruiting ubiquitin ligases appeared fully capable of inducing the release of VLPs using
the Class E VPS machinery, despite the absence of ubiquitin acceptor sites in the viral
protein.

A catalytically active ubiquitin ligase (WWP1) can stimulate budding of a viral
protein lacking ubiquitin acceptors
PPxY-dependent virus budding can sometimes be stimulated by overexpression of
a HECT ubiquitin ligase. This effect is particularly evident with an attenuated MLV
PPxY mutant exhibiting a partial budding defect that can be rescued by WWP1
overexpression [115]. Notably, overexpression of YFP-WWP1 markedly enhanced the
release of particles generated by Lck-Gag-PY (Fig. 13A). This effect required the PPxY
motif in Lck-Gag-PY, because PSAP-dependent Lck-Gag VLP release was not enhanced
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(Fig. 13B), and release of an Lck-Gag lacking a functional late domain was not induced
by WWP1 overexpression (Fig. 13C). Despite the fact that Lck-Gag-PY lacked ubiquitin
acceptor sites, stimulation of VLP release required WWP1 catalytic activity. Indeed,
expression of a truncated WWP1 lacking the catalytic domain (WWP1-ΔHECT) or an
enzymatically inactive point mutant [WWP1(C890S)] inhibited rather than stimulated
Lck-Gag-PY release (Fig. 13A). Again, these effects were specific to the PPxY late
domain, as PSAP-dependent and late domain-independent Lck-Gag VLP release was not
affected (Fig. 13B). Thus, Lck-Gag-PY can recruit WWP1, but the effect of this
recruitment on particle budding was critically dependent on the catalytic activity of
WWP1, even in the complete absence ubiquitin acceptor sites in the viral protein.

Figure 13. Ubiquitin-ligase-stimulated, PPxY-dependent budding of lysine-free Gag.
Western blot (αPFV) analysis of Gag expression and VLP production by 293T cells
expressing lysine-free Lck-Gag proteins: Lck-Gag-PY (A); Lck-Gag(K396R) (B); or
Lck-Gag(PSAP-)(K396R) (C). Each Lck-Gag protein was coexpressed with unfused YFP
as a control or YFP fused to WWP1, WWP1 lacking the HECT domain (WWP1ΔHECT), or a catalytically inactive mutant of WWP1 [WWP1(C890S)], as indicated.
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Effects of addition of ubiquitin acceptor sites on Gag ubiqitination
To exclude the possibility that our PFV Gag proteins became ubiquitinated by an
alternative mechanism, independent of lysine or amino terminal acceptors, we determined
whether ubiquitinated Gag proteins were generated in our assays. As a positive control,
we prepared an Lck-Gag expression plasmid containing late domain-proximal ubiquitin
acceptors by appending three lysine residues to the C-terminus of Lck-Gag-PY
(generating Lck-Gag-PY-3K, Fig. 14A). We immunoprecipitated Lck-Gag proteins from
293T cell lysates, prepared twenty-four hours after co-transfection with plasmids
expressing (i) Lck-Gag variants, (ii) HA-tagged ubiquitin, and (iii) wild-type or inactive
mutant WWP1. Thereafter, ubiquitinated Lck-Gag species were detected by
immunoblotting. Lck-Gag proteins were efficiently immunoprecipitated and detected
using αPFV antibody (Fig. 14B), but ubiquitinated Lck-Gag was undetectable in cells
expressing lysine-free proteins, regardless of which late domain was present, and even
when WWP1 was overexpressed (Fig. 14B). However, immunoprecipitates from cells
expressing Lck-Gag-PY-3K contained several HA-reactive species corresponding to
mono and oligoubiquitinated Gag (Fig. 15B upper panel). A secondary band of slightly
higher molecular weight than Lck-Gag-PY-3K, likely corresponding to a
monoubiquitinated species, was also detected using αPFV in cells expressing Lck-GagPY-3K, but not Lck-Gag-PY (Fig. 15B, center and lower panels). These ubiquitinated
forms reflect HECT ligase-mediated ubiquitination, as they were observed only in cells
overexpressing catalytically active, but not catalytically inactive, WWP1. Thus, despite
the ability of Lck-Gag-PY to recruit a ubiquitin ligase, its ubiquitination was detected
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Figure 14. Lysine-dependent, WWP1-induced ubiquitination of Lck-Gag. (A) Schematic
representation of the Lck-Gag protein appended with the MLV late domain and three
lysine residues at its C terminus (Lck-Gag-PY-3K). (B) Western blot
(WB)/immunoprecipitation (IP) analysis of Lck-Gag proteins encoding the indicated late
domains from 293T cells cotransfected with plasmids expressing Lck-Gag proteins, HAubiquitin, and unfused YFP, YFP-WWP1, or YFP-WWP1(C890S). All Lck-Gag proteins
were lysine free except Lck-Gag-PY-3K. (Top and Middle) The αPFV
immunoprecipitates were analyzed by Western blotting with an αHA monoclonal
antibody (Top) or αPFV serum (Middle). (Bottom) Alternatively, unfractionated cell
lysates were probed with αPFV serum. For the αHA blot, the migration of molecular
weight markers is indicated to facilitate assignment of ubiquitinated forms.
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only as a consequence of insertion of lysine residues at the C-terminus. Therefore, lysinefree Lck-Gag proteins appear to be resistant to ubiquitination by WWP1.

Lck-Gag ubiquitination does not enhance particle release
We next determined whether the presence of ubiquitin acceptors, and ubiquitin
conjugation, could enhance PPxY-dependent particle release. First, we compared LckGag-PY with Lck-Gag-PY-3K, whose release is dependent on HECT ubiquitin ligases
and differ only in the presence or absence of late domain-proximal ubiquitin acceptors.
Notably, Lck-Gag-PY-3K generated extracellular VLPs with no greater efficiency than
lysine-free Lck-Gag-PY (Fig. 15A, left panel). Moreover, ubiquitinated Gag species were
detectable in VLPs assembled by Lck-Gag-PY-3K, but not lysine free Gag proteins (Fig.
15A, right panel). Thus, under conditions where ubiquitinated Gag is, or is not,
generated, VLP release was equivalent. Additionally, WWP1 stimulated the release of
particles generated by using Lck-Gag-PY-3K (Fig. 15B, C). Importantly, the magnitude
of this effect was no greater than that observed with lysine-free Lck-Gag (Fig. 15B).
Thus, WWP1-stimulated, PPxY-dependent particle release occurred equivalently whether
or not it was accompanied by Gag ubiquitination.

Summary
We generated a plasma membrane-targeted lysine-free PFV Gag protein (LckPFV Gag) that can assemble at the cell surface and form extracellular virus-like particles
in the absence of other viral protein expression. Notably, direct Gag ubiquitination was
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Figure 15. Presence of ubiquitin acceptors or Gag ubiquitination does not affect
ubiquitin-ligase-induced Lck-Gag budding. (A) Western blot analysis of VLP production
by 293T cells coexpressing HA-ubiquitin and the indicated PFV Gag proteins. VLP
lysates were analyzed by Western blotting with αPFV serum (Left) or monoclonal αHA
antibody (Right). Migration of molecular weight markers is indicated to facilitate
assignment of ubiquitinated forms. (B) Western blot (αPFV) analysis of VLP production
by Lck-Gag-PY proteins that were lysine-free or that bore three appended lysine residues
at the C- terminus, as indicated. The Lck-Gag-PY proteins were expressed either with
unfused YFP, as a control, or with YFP-fused WWP1, as indicated.
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dispensable for both PSAP- and PPxY-dependent budding of Lck-PFV Gag. Moreover,
overexpression of HECT ubiquitin ligase WWP1 specifically stimulated PPxY-dependent
particle production by lysine-free Lck-Gag. Importantly, the catalytic activity of WWP1
was required to promote PPxY-dependent budding in the presence and absence of
ubiquitin acceptor sites within Gag. Taken together, our findings suggest that HECT
ligases mediate late domain dependent budding by ubiquitinating transacting cellular
factors and that ubiquitination of Gag is merely a side effect of ubiquitin ligase
recruitment.
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Chapter IV. Comparative analysis of HECT domain function

The Class E VPS pathway must be intact to support HECT ubiquitin ligasedependent virion release. The yeast HECT ligase Rsp5 is dispensable for MVB
biogenesis but required for sorting of some endosomal cargoes [225]. In essence, PPxY
late domains allow viral Gag proteins to be recognized by the Class E pathway as a
specific type of cargo by recruiting HECT ligases, but the biochemical link between the
ligases and the VPS machinery remains elusive.
A wild-type catalytic domain is essential for HECT ligase-mediated enhancement
of PPxY-dependent budding [115,255], but the precise mechanism of this stimulation is
unclear. Expression of enzymatically inactive WWP1, containing a single point mutation
that disrupts its active site (C890S), fails to stimulate PPxY-dependent budding ([115]
and Fig. 14B). Moreover, expression of truncated WWP1, lacking the entire catalytic
domain, induces a more potent dominant negative effect on MLV budding than
overexpression of the catalytic point mutant [115], suggesting that the HECT domain
may encode additional elements that contribute to its ability to engage the Class E VPS
machinery. Indeed, WWP1 localizes to aberrant endosomal compartments induced by
overexpression of dominant negative Vps4, and this recruitment is largely dependent on
its HECT domain [115]. Thus, HECT domains may mediate the interaction of full-length
ubiquitin ligases with VPS factors, which are trapped on these aberrant compartments.
Such interactions have not been convincingly documented by protein-protein binding
assays and may be indirect, requiring unidentified bridging factors.

57

Nine members of the Nedd4-like HECT ubiquitin ligase family have been
described in humans, with regulatory roles in cell signaling, endocytosis, protein
trafficking, and viral budding (reviewed in [209]). These ubiquitin ligases vary in their
ability to promote PPxY-dependent MLV virion release, due at least in part to differences
in the abilities of their WW domains to bind the MLV late domain [115]. A comparative
analysis of HECT domain activities, including substrate ubiquitination and budding
stimulation, could provide useful clues about their mechanistic role in VPS pathway
engagement.

Catalytically active HECT domains stimulate PPxY-dependent budding with
variable efficiency
To distinguish the features of HECT domains that are important for stimulation of
virus particle release we compared the various activities of isolated HECT domains.
Since WWP1 has been previously shown to strongly interact with the MLV late domain
[115], we constructed a series of chimeric ubiquitin ligases, consisting of the membrane
targeting and PPxY motif-binding domains (C2-WW) of human WWP1 and different
catalytic domains, derived from human WWP2, Nedd4, Nedd4L, Itch, Smurf1, or Bul2 or
yeast Rsp5 HECT ligases (Fig. 16A). Overexpression of chimeric HECT ligases
markedly reduced the expression of MLV GagPol in cell lysates (data not shown),
perhaps by inducing its degradation, making it difficult to compare their effects on
budding. Thus, we used a Gag protein containing minimal ubiquitin acceptor lysine
residues. Lysine-free Prototype foamy virus (PFV) Gag (Lck-PFV Gag) can assemble at
the plasma membrane and bud in the absence of other viral protein expression, using both
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Figure 16. Stimulation of PPxY-dependent VLP production by chimeric HECT ligases.
(A) Schematic representation of YFP-fused chimeric ubiquitin ligases containing the
membrane targeting (C2) and late domain binding (WW) domains of WWP1 and the
indicated catalytic HECT domains. Wild-type and catalytically inactive mutant (C-S)
versions of each HECT ligase were constructed. (B) Quantitative Western blot (LICOR)
analysis of VLP release from 293T cells coexpressing Lck-Gag-PY and the indicated
chimeric HECT ligases.
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its naturally encoded PSAP late domain or a heterologous PPxY late domain, derived
from MLV Gag. Expression of ubiquitin ligases containing any wild-type HECT domain,
except that of human WWP2 and yeast Rsp5, stimulated PPxY-dependent budding of
lysine-free Lck-PFV Gag (Fig. 16B). The strongest stimulation was observed with
Nedd4L and Itch HECT domains. In contrast, overexpression of all enzymatically
inactive chimeric ligases, in which the catalytic cysteine was mutated to serine, inhibited
PPxY-dependent VLP production, suggesting that the catalytic activity of HECT domains
is indispensable for stimulation of virion release.

Stimulation of PSAP-dependent VLP release by recruitment of catalytically active
HECT domains
The VPS factor Tsg101 functions essentially as an adaptor protein, which recruits
ESCRT-I proteins to Gag. The N-terminal ubiquitin E2 variant (UEV) domain of Tsg101
interacts with ubiquitin and P(T/S)AP peptide motifs [103,147,148,256], whereas the Cterminal portion of the protein interacts with ESCRT-I components Vps28 and Vps37
[149,241,257]. To determine whether P(T/S)AP-dependent VLP production can be
redirected through the ubiquitin ligase-dependent pathway, we constructed chimeric
proteins containing the UEV domain (residues 1-157) of Tsg101 fused to one of several
human HECT domains (Fig. 17A). To assess the enhancement of PSAP-dependent
budding, we constructed an attenuated “leaky” budding mutant of Lck-PFV Gag by
changing the first proline residue of the PSAP motif to alanine. Expression of chimeric
Tsg-HECT proteins containing wild-type WWP1 and Nedd4L HECT domains induced
partial rescue of Lck-Gag-ASAP budding, while expression of a chimeric protein
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containing the Itch catalytic domain completely rescued particle production.
Overexpression of catalytically inactive chimeric Tsg-HECT proteins inhibited Lck-PFV
Gag-ASAP VLP release (Fig. 17B). Thus, ubiquitin ligase activity at sites of VLP
assembly appears to stimulate particle production, irrespective of its mode of recruitment
to Gag.

Figure 17. Stimulation of PSAP-dependent budding by catalytically active HECT
domains. (A) Schematic representation of a chimeric ubiquitin ligase containing the UEV
domain of Tsg101 (PSAP binding) and the catalytic domain of a HECT ligase. (B) VLP
production from 293T cells expressing Lck-PFV Gag containing either a wild-type
(PSAP), inactive (ΔPSAP), or attenuated (ASAP) late domain and the indicated chimeric
ubiquitin ligase.

62

Stimulation of PFV Gag budding correlates with HECT ligase auto-ubiquitination
rather than Gag ubiquitination
To assess the relative catalytic activities of HECT domains, we compared the
abilities of chimeric HECT ligases to ubiquitinate themselves and a PFV Gag substrate,
encoding three lysine residues in close proximity to a PPxY late domain (Lck-Gag-PY3K). We immunoprecipitated PFV Gag and HECT ligases from 293T cell lysates,
prepared 36 hours after co-transfection with plasmids expressing Lck-Gag-PY-3K, HAtagged ubiquitin, and YFP-fused chimeric HECT ligases encoding wild-type catalytic
domains. Cell lysates were prepared using detergent-rich buffer (0.5% SDS) to ensure
complete dissolution of protein complexes, and ubiquitinated species were detected by
immunoblotting with an αHA antibody.
All of the tested chimeric ligases induced PPxY-dependent PFV Gag
ubiquitination (Fig. 18A), but no correlation between direct Gag ubiquitination and
stimulation of VLP production was apparent. Bul2 and Nedd4 HECT domains, which
induced the highest and lowest levels of Gag ubiquitination, respectively, stimulated
budding to a similar extent (about 6-fold). Moreover, the Rsp5 HECT domain, which
induced high levels of Gag ubiquitination, enhanced budding only marginally.
In contrast, we observed a broad, albeit imperfect correlation between the ability
of HECT ligases to self-ubiquitinate and to stimulate VLP production (Fig. 18B). Ligases
that strongly promoted particle release (Itch and Nedd4L HECT domains) carried more
ubiquitin, while those that failed to promote VLP release (WWP2 and Rsp5 HECT
domains) carried relatively little. The correlation was imperfect, however, since Nedd4,
which moderately enhanced particle release, was consistently highly ubiquitinated.
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Figure 18. Chimeric HECT ligases induce different levels of Gag- and autoubiquitination. Quantitative Western blot analysis of lysine-containing PFV Gag proteins
(A) and chimeric HECT ligase proteins (B), immunoprecipitated from 293T cells cotransfected with plasmids expressing Lck-Gag-PY-3K, HA-ubiquitin, and the indicated
chimeric YFP-HECT ligases. The αPFV immunoprecipitates were probed with an αHA
monoclonal antibody (A, top) or αPFV serum (A, middle). The αGFP
immunoprecipitates were probed with αHA (B, top) and αGFP (B, middle) monoclonal
antibodies. Alternatively, unfractionated cell lysates were probed with αPFV serum or
αGFP antibody (A and B, bottom).
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Notably, all HECT domains localized to Vps4-induced Class E compartments, but there
was no apparent correlation between their recruitment to class E compartments and
ability to stimulate budding (Fig. 19).
Our data support our previous finding that direct Gag ubiquitination is
dispensable for HECT ligase-dependent budding [255] and suggest a hypothesis that the
total amount of ubiquitin deposited at sites of virion assembly is important for stimulation
of particle release, rather that the identity of the protein to which it is ligated. HECT
ligase auto-ubiquitination might account for the majority of total ubiquitin present in the
vicinity of PPxY-dependent Gag assembly. However, we have been unable to directly
assess the total levels of protein ubiquitination induced by each chimeric ligase when it is
in a complex with Gag, due to the inefficient solubility of the ubiquitinated complexes
under conditions that preserve protein-protein interactions. Thus, we cannot rule out the
possibility that HECT domains recruit VPS proteins, either directly or through bridging
factors, since auto-ubiquitination of HECT ligases may enhance their affinity for
downstream binding partners that, in turn, could allow Class E pathway engagement.

Stimulation of PPxY-dependent budding by direct recruitment of ESCRT-I
To determine whether the requirement for enzymatically active ubiquitin ligase
recruitment for PPxY-dependent budding could be bypassed, we constructed chimeric
proteins by replacing the HECT domain of WWP1 with the C-terminal portion of Tsg101
(TsgΔUEV, residues 157-390, Fig. 20A). Overexpression of WWP1-TsgΔUEV
stimulated Lck-PFV Gag-PY budding in a dose-dependent manner but had no effect on
particle production by late domain-deficient PFV Gag (Fig. 20B, left and middle panels).
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Figure 19. HECT domain recruitment to dominant negative Vps4-induced Class E
compartments. Subcellular localization of indicated YFP-HECT domains in 293T cells
coexpressing CherryFP-Vps4(E228Q).
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Thus, the chimeric protein seems capable of recruiting a functional ESCRT-I complex to
assembling virions that encode PPxY late domains, thereby stimulating VLP production.
Interestingly, WWP1-TsgΔUEV overexpression inhibited PSAP-dependent Lck-PFV
Gag budding in a dose-dependent manner (Fig. 11B, right panel). Presumably, since the
chimeric protein lacks the structural elements required for interaction with PSAP motifs,
it can act as a dominant negative inhibitor of PSAP-dependent budding by sequestering
endogenous ESCRT-I components into complexes that cannot bind to PTAP motifs.

Figure 20. Stimulation of PPxY-dependent budding by direct recruitment of ESCRT-I.
(A) Schematic representation of a chimeric protein designed to recruit ESCRT-I to PPxY
late domains, containing the C2 and WW domains of WWP1 fused to a Tsg101 fragment
lacking the UEV domain (TsgΔUEV). (B) VLP production from 293T cells expressing
Lck-PFV Gag containing the indicated late domain and increasing amounts of YFPWWP1-TsgΔUEV.
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Summary
Humans encode several Nedd4-like ubiquitin ligases, which vary in their ability to
stimulate PPxY-dependent MLV budding. HECT ligases may promote budding either by
recruiting cellular factors to sites of virus particle assembly or by depositing ubiquitin
onto proteins in the vicinity. To distinguish between these two alternatives we compared
the capacity of different catalytic HECT domains to stimulate PFV budding and
ubiquitination. We generated chimeric ubiquitin ligases that interact with either PPxY or
PT/SAP-type late domains and contain different HECT domains. The ability of these
ligases to stimulate PFV particle production was absolutely dependent on their catalytic
activity, irrespective of their mode of recruitment to Gag. Moreover, the efficiency with
which they stimulated budding correlated with the extent of their auto-ubiquitination.
Interestingly, PPxY dependent budding could be enhanced in the absence of ubiquitin
ligase activity by expression of a chimeric protein that directly recruits the ESCRT-I
complex.
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Chapter V. Direct ubiquitin fusion to Gag replaces late
domain function

Stimulation of PPxY-dependent viral budding is strictly dependent on the
catalytic activity of HECT ubiquitin ligases. However, the strength of the stimulation
correlates, broadly, with the extent of HECT ligase autoubiquitination rather than Gag
ubiquitination. This is consistent with several possible models for HECT ligase-mediated
budding. HECT domains may contain structural elements that are normally inaccessible
but can be activated to engage the Class E VPS pathway by conformational changes,
induced by ubiquitination. Alternatively, HECT domains may contain suboptimal binding
sites, whose affinity for class E factors or bridging factors is enhanced by ubiquitination.
Finally, ubiquitin itself could serve as a docking site for Class E factors, many of which
contain ubiquitin interacting motifs, and the actual identity of the substrate for
ubiquitination may be unimportant, provided that it is proximal to the site of particle
budding. In this case, HECT ligase autoubiquitination could simply represent the
majority of ubiquitin present at viral assembly sites, since ubiquitin acceptor lysine
residues are much more abundant in the ligases than in PFV Gag.
If the substrate for HECT ligase-mediated ubiquitination is indeed irrelevant, and
PPxY late domains merely serve to concentrate ubiquitinated protein species in the
vicinity of virus particle assembly, direct fusion of ubiquitin to Gag may obviate the need
for a conventional late domain. Two previous studies have described late domain-like
activity of ubiquitin that has been appended directly to Gag. Ubiquitin fusion to the Cterminus of RSV Gag rescues virus-like particle production in cells treated with
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proteasome inhibitors but fails to compensate for the deletion of the PPxY late domain
[104]. Fusion of ubiquitin to EIAV Gag promotes VLP release by late domain-deficient
Gag but does not enhance budding of Gag encoding functional late domains [258].
Moreover, ubiquitin-dependent budding of EIAV Gag requires an intact Class E VPS
pathway and a key hydrophobic surface patch of ubiquitin that mediates its recognition
by ubiquitin-binding proteins. Lysine free PFV Gag, which cannot otherwise be modified
by ubiquitin, offers a unique context for testing the effect of Gag-ubiquitin fusion on VLP
production.

Direct fusion of ubiquitin to PFV Gag promotes VLP release in the presence and
absence of conventional late domains
To mimic the deposition of ubiquitin at sites of virion assembly without HECT
domain recruitment we generated membrane targeted PFV Gag constructs with a single
ubiquitin appended at the C-terminus. Ubiquitin is conjugated to proteins by an
isopeptide bond between the C-terminal glycine residue of ubiquitin and the ε-amino
group of a lysine residue within the substrate protein. Thus, to avoid aberrant linkage of
our Gag-ubiquitin chimeras to other proteins we deleted two glycine residues from the Cterminus of ubiquitin (Fig. 21A).
Remarkably, cells expressing ubiquitin-fused late domain-deficient Lck-PFV Gag
(ΔPSAP-Ub) efficiently produced VLPs, whereas those expressing its unfused
counterpart (ΔPSAP) produced undetectable levels (Fig. 21B, left panel). Moreover,
attachment of ubiquitin to the C-terminus of PFV Gag containing a wild-type late domain
(PSAP-Ub) greatly enhanced its particle production (Fig. 21B, right panel). To determine
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the amount of ubiquitin necessary to promote PFV budding we titrated ubiquitin-fused
Gag in a VLP production assay while keeping total levels of Gag constant. In the absence
of conventional late domains, almost all of the Gag proteins must carry ubiquitin to
support efficient VLP release (Fig. 21D, left panel). However, in the presence of a PSAP
late domain, potent stimulation of VLP release was observed when only 25% of Gag
carried ubiquitin (Fig. 21D, right panel). Thus, ubiquitinated species be present at sites of
VLP assembly stimulate budding, in an apparently dose dependent manner. Moreover,
ubiquitin appears to synergize with a late domain (i.e. a PTAP motif) to promote efficient
VLP release.
Several enveloped viruses encode both PT/SAP and PPxY motifs within a single
structural protein, with one typically playing a dominant role in promoting particle
release. The activity of the secondary late domain usually becomes apparent only when
the primary late domain is inactivated [193,259,260,261]. In the case of lysine-free LckPFV Gag, PSAP- and PPxY-dependent budding is relatively inefficient. However, when
both late domains are present together within the same Gag protein, their activities appear
to synergize, resulting in potent stimulation of VLP release (Fig. 21C). Direct fusion of
ubiquitin to the C-terminus of Gag presumably mimics the effect of efficient recruitment
of a highly active ubiquitin ligase by a PPxY-type late domain. Hence, ubiquitin fusion to
PFV Gag induces greater stimulation of VLP release than addition of a PPxY late
domain. Moreover, particle production can be further enhanced by fusing ubiquitin to
PFV Gag that encodes both the PSAP and PPxY late domains (Fig. 21C).
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Figure 21. Direct fusion of ubiquitin to Lck-PFV Gag stimulates late domain-dependent
and -independent budding. (A) Schematic representation of lysine-free Lck-PFV Gag
with a single ubiquitin moiety fused at the carboxy terminus. Two glycine residues were
removed from the C-terminus of ubiquitin to prevent its conjugation to other proteins.
(B) VLP production from 293T cells expressing the indicated Lck-PFV Gag constructs.
(C) Relative VLP release efficiency by 293T cells expressing Lck-PFV Gag containing
the indicated late domains, alone or in combination with ubiquitin fusion, measured by
quantitative western blot. (D) VLP production from 293T cells expressing Lck-Gag and
Lck-Gag-Ub containing either the wild-type (PSAP) or inactive (ΔPSAP) late domain.
Cells were transfected with equal total amounts of Gag DNA, with the indicated fraction
of Lck-Gag-Ub.
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Ubiquitin-directed PFV budding is Class E pathway-dependent
Ubiquitin possesses several residues required for its polymerization and
recognition by cellular signaling factors. Lys48 and Lys63 are involved in the formation
of polyubiquitin chains, which target proteins for proteasomal degradation [262,263,264]
or other regulatory events [264,265,266,267,268], respectively. Gln62 and Glu64 have
been implicated in binding Tsg101 and its yeast homolog Vps23 [269]. Phe4 is important
for ubiquitin-mediated receptor protein internalization [270,271]. Leu8 and Ile44 are key
residues in a hydrophobic patch [271,272,273] that forms an essential interaction surface
for numerous cellular proteins, including some VPS proteins (summarized in Table 5).
Notably, overexpression of ubiquitin with mutated Phe4 and Ile44 residues has been
shown to inhibit HIV-1 VLP production [273]. Mutagenic disruption of the Leu8/Ile44
hydrophobic patch strongly inhibited ubiquitin-dependent rescue and enhancement of
PFV Gag budding, whereas the other residues appeared to be dispensable (Fig. 22A).
Thus, ubiquitin seems to mediate VLP production by recruiting cellular factors to sites of
virion assembly, in effect serving as a late domain.
The function of all conventional retroviral late domains requires an intact Class E
VPS pathway [103,108,122,123,124]. Thus, if budding of ubiquitin-fused Gag occurs by
the same mechanism as that of PPxY-containing Gag, it should be inhibited by disruption
of the Class E machinery. Indeed, budding of Lck-PFV-ΔPSAP-Ub and Lck-PFV-PSAPUb was suppressed in a dose-dependent manner by overexpression of dominant negative
Vps4 (E228Q) (Fig. 22B), indicating that ubiquitin can promote particle release only in
cells with an intact Class E pathway.
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Figure 22. Ubiquitin-dependent VLP production requires Class E VPS machinery
engagement. (A) VLP release from 293T cells expressing Lck-Gag-Ub containing either
the wild-type or inactive late domain and the indicated mutations in ubiquitin. (B) VLP
production from 293T cells expressing Lck-Gag-Ub containing either the wild-type or
nonfunctional late domain and increasing amounts of GFP-Vps4 (E228Q).

75

Several Class E factors bind ubiquitin
Several Class E vacuolar protein sorting factors have been reported to encode
ubiquitin interacting motifs (Table 5). Although the affinity of such domains for
monoubiquitin is relatively weak (Kd >100µM), many Class E factors form multiprotein
complexes that potentially contain several ubiquitin-binding surfaces, which could
provide sufficient avidity for their interaction with ubiquitinated proteins. The efficiency
with which ESCRT complexes are recruited to viral assembly sites would would likely be
dependent on the concentration of ubiquitin in the vicinity of VLP assembly, which is
consistent with our finding that a large fraction of Gag must carry ubiquitin to
compensate for the absence of a late domain (Fig. 21D). We performed a yeast twohybrid assay to survey the binding of various Class E factors to ubiquitin containing
either an intact (WT) or disrupted hydrophobic patch (I44A). Several factors exhibited
binding interactions above background levels (Fig. 23); however, only HBP/STAM,
CIN85, ALIX, and UBPY binding appeared to require the Ile44 hydrophobic patch. We
note that multiple subunits of the ESCRT-I complex have been reported to bind ubiquitin
or have domains that are predicted to bind ubiquitin [103,147,148,257,274], and while we
were not able to detect interactions with individual subunits in out yeast two hybrid
assays, it is quite possible, and even likely, that the complete ESCRT-I complex binds
ubiquitin.
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Table 5. Mammalian Class E factors encoding ubiquitin binding domains
Class E factor Domain type
Tsg101

UEV

Vps37A

putative UEV

Kd

Methods

References

~500µM

SPR, NMR, structure

[103,147,148,274]

sequence

STAM

UIM, VHS

~430µM, ~220µM

IP, NMR

[257]
[161,274,275,276,277,
278,279]
[155,160,161,280]

Eap45

GLUE

~300µM

IP, SPR, structure

[166,281,282]

Eps15

UIM

IP, SPR

[277,279]

ALIX

Unknown

IP

[258]

CIN85

SH3

IP, NMR

[283]

Hrs

DUIM, VHS ~300µM, ~1.4mM

IP, SPR, structure

SPR: surface plasmon resonance, NMR: nuclear magnetic resonance

Figure 23. Several Class E vacuolar protein sorting factors interact with ubiquitin in a
hydrophobic patch-dependent manner. Yeast two-hybrid analysis of the interaction
between the indicated Class E factors and ubiquitin containing either an intact (Ub WT)
or disrupted (Ub I44A) hydrophobic patch. β-galactosidase expression was measured as
optical density at 540nm (OD540) in Y190 cells transformed with the indicated Gal4DNA binding domain (Gal4-BD) or activation domain (Gal4-AD) fusion constructs.
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Perturbation of Class E factor function modestly affects ubiquitin-dependent
budding
We sought to determine the sensitivity of ubiquitin-dependent rescue of PFV
budding to perturbation of different branches of the Class E pathway. Therefore, we
tested the efficiency of Lck-PFV Gag-ΔPSAP-Ub particle release in cells overexpressing
either full length or putatively dominant negative fragments of several Class E factors
with reported ubiquitin binding activity. Overexpression of the Tsg101 UEV domain,
which binds ubiquitin but lacks the ability to recruit downstream components of the
ESCRT pathway, inhibited ubiquitin-dependent budding of Lck-PFV Gag to a similar
extent as P(T/S)AP-dependent budding of Lck-PFV Gag and HIV-1 Gag (about 3-fold,
Fig. 24A). However, mutation of the ubiquitin-binding site of TsgUEV (N45A,
[147,148]) had no effect on its ability to inhibit Lck-PFV budding (data not shown).
Since the UEV domain interacts with PT/SAP motifs as well as ubiquitin, the N45A
mutant UEV could, in theory, be recruited to Gag-ubiquitin assembly sites indirectly, by
binding ESCRT-0 through the PSAP motif in Hrs.
PSAP- and ubiquitin-dependent PFV Gag budding were both modestly inhibited
by overexpression of Hrs, containing either a wild-type or mutated (LA265,266AL)
ubiquitin binding pocket [159,277] (Fig. 24E and data not shown). Endogenous Hrs
localizes to early endosomes, and its overexpression causes Tsg101 redistribution from
late to early endosomes [158]. Moreover, overexpression of Hrs has been shown to
inhibit HIV-1 budding by a mechanism that requires its interaction with Tsg101 [284].
Overexpressed Hrs may, therefore, inhibit ubiquitin-dependent budding, independently of
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Figure 24. Effect of Class E factor overexpression on ubiquitin-dependent budding of late
domain-deficient PFV Gag. Quantitative Western blot analysis of relative VLP
production by 293T cells expressing Lck-PFV Gag-ΔPSAP-Ub and increasing quantities
of GFP-Tsg101UEV (A), YFP-ALIX (B), YFP-ALIX-ΔPRR (C), YFP-ALIX-ΔBro (D),
YFP-Hrs (E), YFP-UBPY (F), or YFP-Eap45 (G). Effect of factor overexpression on
VLP release from 293T cells expressing Lck-PFV Gag-PSAP (A, E, and G), HIV-1 Gag
(A), HIV-1 HXB-ΔPSAP proviral plasmid (B), and EIAV Gag (C and D) is shown for
comparison.
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its own ability to interact with ubiquitin, by sequestering endogenous Tsg101 away from
sites of virus particle assembly.
Expression of full length ALIX at concentrations that strongly stimulated budding
of HIV-1 encoding a mutated PTAP motif [196] marginally enhanced ubiquitindependent Lck-PFV Gag budding (Fig. 24B). Converesely, overexpression of ALIX
fragments lacking either the Bro1 domain or the proline-rich region, which are important
for interactions with CHMP4 and Tsg101, respectively [108,122,123,197,198], exhibited
a strong dominant negative effect on YPDL-dependent EIAV budding and had no effect
on Lck-PFV Gag-ΔPSAP-Ub budding (Fig. 24C, D).
Overexpression of the wild-type and catalytically inactive deubiquitninating
enzyme UBPY had no appreciable effect on ubiquitin-dependent VLP production (Fig.
24F and data not shown). Overexpression of the ESCRT-II protein EAP45 slightly
inhibited ubiquitin-dependent Lck-PFV Gag budding, and the inhibition was unaffected
by mutations in the ubiquitin binding site of EAP45 (VFE67,68,70AAA [281,282]) (Fig.
24G and data not shown).

Inhibition of ubiquitin-dependent budding by Class E factor depletion
Overall, the effects of ESCRT protein overexpression on ubiquitin dependent
budding were rather modest and difficult to interpret. Therefore, We next determined the
effect of siRNA depletion of ubiquitin-binding Class E factors on Lck-PFV Gag budding.
Due to the inefficient knockdown of Hrs (Fig. 25E), its effect on budding could not be
reliably assessed. We did not test the effect of STAM depletion, since it cannot associate
with membranes or interact with the ESCRT pathway in the absence of Hrs [155,158],
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Figure 25. Inhibition of Lck-PFV Gag budding by Class E factor depletion is late
domain-specific. (A-D) Quantitative Western blot analysis of VLP production from 293T
cells expressing Lck-PFV Gag-ΔPSAP-Ub (A), Lck-PFV Gag-PY (B), Lck-PFV GagPSAP (C), or EIAV Gag (D) and siRNAs directed against the indicated Class E factors.
(E) Quantitative Western blot analysis of siRNA Class E factor depletion. Lysates of
293T cells transfected with GFP-Tsg101 or YFP-Hrs, -ALIX, -UBPY, or -Eap45
expression plasmids and siRNAs targeting either luciferase (Control) or the specified
Class E factors were probed with αGFP monoclonal antibody.
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and thus appears to play an auxiliary role in ubiquitinated cargo recognition.
Nevertheless, ubiquitin-dependent budding was modestly inhibited by depletion of
Tsg101 or ALIX (2-3-fold) but not by depletion of UBPY or EAP45 (Fig. 25A). PPxYdependent budding of PFV Gag exhibited a similar pattern of inhibition by Class E factor
knockdown but appeared to be more sensitive to Tsg101 depletion (Fig. 25B). In contrast,
PSAP-dependent Lck-PFV Gag budding was specifically inhibited by depletion of
Tsg101 (over 5-fold inhibition, Fig. 25C) and EIAV Gag budding was specifically
inhibited by depletion of ALIX (about 4-fold inhibition, Fig. 25D).
Several Class E factors may serve redundant roles in recognizing ubiquitinated
species and mediating ubiquitin-dependent virus particle release. Thus, we sought to
determine whether simultaneous depletion of multiple factors, specifically Tsg101 and
ALIX, would exhibit a stronger inhibitory effect on budding than depletion of individual
factors. Class E factor knockdown was significantly less efficient under the conditions
used for this assay (Fig. 26C), which may account for the lack of inhibition of VLP
release by expression of siRNAs targeting ALIX. Nevertheless, cotransfection of Tsg101
and ALIX siRNAs together had a significantly stronger inhibitory effect on both
ubiquitin- and PPxY-dependent Lck-PFV Gag budding than expression of either siRNA
alone (Fig. 26A, B).

Summary
We generated ubiquitin-fused PFV Gag proteins to mimic ubiquitin deposition at
viral assembly sites in the absence of HECT domain recruitment. Remarkably, direct
fusion of ubiquitin to the carboxy terminus of PFV Gag enabled budding and in the

84

Figure 26. Depletion of multiple Class E factors enhances VLP release inhibition. (A and
B) Quantitative Western blot analysis of VLP production from 293T cells expressing
Lck-PFV Gag-ΔPSAP-Ub (A) or Lck-PFV Gag-PY (B) and siRNAs targeting the
indicated Class E factors. Cells transfected with a single Class E factor siRNA were cotransfected with an equal amount of control siRNA to keep total siRNA levels constant.
(C) Quantitative Western blot analysis of ectopically expressed fluorescent protein-fused
Class E factor depletion in 293T cells transfected with multiple siRNAs. Cell lysates
were probed with αGFP monoclonal antibody.
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absence of a conventioan L-domain, and potently stimulated PSAP-dependent budding.
Ubiquitin-dependent particle production was abolished by overexpression of dominant
negative Vps4 and diminished by mutations within the ubiquitin hydrophobic patch.
Depletion of individual class E factors partially suppressed ubiquitin-dependent budding,
and the effect was enhanced by simultaneous depletion of Tsg101 and ALIX, suggesting
that their interactions with ubiquitin provide redundant mechanisms for VPS pathway
engagement.
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Chapter VI. Discussion

Efficient separation of nascent virions from the plasma membrane requires
engagement of the cellular Class E VPS pathway by late domains, short peptide motifs
encoded within viral structural proteins. PT/SAP and YPxL/LxLF-type late domains
recruit VPS factors with well-documented physical links to the ESCRT-III complex of
the pathway, which is thought execute the membrane scission event critical for release of
virons. On the other hand, PPxY late domains recruit Nedd4-like HECT ubiquitin ligases,
which require their catalytic domains and an intact Class E pathway for their function in
virus release. However, the mechanism of Class E machinery engagement by HECT
ligases is poorly understood. Moreover, ubiquitin plays a general role in late domaindependent budding, as its depletion arrests the release of viruses that utilize different late
domains at a late stage of budding, but its precise function is unclear.
The major structural proteins of several retroviruses become ubiquitinated as a
consequence of late domain activity; however, it is unclear whether these modifications
play a functional role in promoting virion release or if they are merely bystander
reactions of promiscuous ubiquitin ligases. Two studies have shown that mutation of
multiple lysine residues in HIV-1 and RSV Gag significantly inhibits particle production
[237,238]. However, the budding defects observed in these studies may have been due to
structural disruptions in Gag rather than the loss of ubiquitin acceptor sites. We took
advantage of a naturally occurring lysine-poor Gag protein (PFV Gag) to generate a
lysine free Gag that could direct the assembly of virus-like particles at the plasma
membrane in the absence of other viral protein expression. Lysine free PFV Gag
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supported efficient PSAP late domain-dependent particle release. Remarkably, direct
ubiquitination of PFV Gag was dispensable for the function of the PPxY late domain,
which nevertheless recruited HECT ligases and required their catalytic activity to
promote budding.
Similar observations have been made with regard to vacuolar sorting of certain
proteins in yeast. For example, recruitment of the yeast HECT ligase Rsp5 by Sna3,
through a PPxY motif in its cytoplasmic tail, promotes Sna3 polyubiquitination and
sorting into the MVB pathway. However, sorting of lysine free Sna3, which does not get
ubiquitinated, still requires the catalytic activity of Rsp5 [225,226,227]. Thus, cargo
protein ubiquitination is not universally required for ubiquitin ligase-dependent
endosomal sorting using the VPS pathway.
In theory, HECT ligases could stimulate viral particle release via the Class E
pathway by numerous mechanisms other than direct viral protein ubiquitination. The
ligases themselves could function as scaffolds for VPS protein recruitment, either directly
or through unidentified bridging factors. Our lab has previously shown that the isolated
HECT domain of WWP1 can behave in soluble Class E factor-like manner, in that it is
retained on aberrant endosomal compartments induced by overexpression of catalytically
inactive Vps4 (E228Q) [115]. Moreover, physical interactions between Class E factors
and HECT ligases have been reported, albeit not necessarily via the HECT domain.
Specifically, Tsg101 can associate with a fragment of Nedd4 containing the C2 and WW
domains [285], and Hrs can associate with and become ubiquitinated by Itch [286].
Alternatively, HECT ligase-mediated ubiquitination could modulate the stability, activity,
or interactions of specific Class E factors or associated proteins. Indeed, several factors
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involved in yeast and human endosomal trafficking can be ubiquitinated by HECT ligases
[286,287]. Finally, since several Class E factors that function early in the pathway
contain ubiquitin-binding domains, HECT ligase-mediated autoubiquitination, or
ubiquitination of trans-acting factors, may serve to concentrate ubiquitinated species at
virion production sites, thereby nucleating the assembly of the Class E machinery.
Since the catalytic domains of HECT ligases are critical for their late domainstimulating ability, we compared the activities of HECT domains from different members
of the human Nedd4-like family of HECT ubiquitin ligases. We found the catalytic
cysteine residue to be strictly required for stimulation of PPxY-dependent budding of
lysine-free PFV Gag. Meanwhile, HECT ligase-mediated stimulation of VLP release did
not correlate with HECT domain recruitment to mutant Vps4-induced Class E
compartments. Thus, the ubiquitin conjugating activity of HECT domains appears to be
critical for their role in particle release, even in the absence of direct Gag ubiquitination.
This is consistent with recent findings that ISG15, a ubiquitin-like molecule, can inhibit
PPxY-dependent release of vesicular stomatitis virus (VSV) and Ebola virus VP40 VLPs
by suppressing the catalytic activity of Nedd4 and several related ubiquitin E3 ligases
[228,229]. It is important to note that ISG15 inhibits Nedd4 autoubiquitination, and not
merely viral protein ubiquitination, by blocking the association of Nedd4 with E2
enzymes and impairing the formation of thioester-bound HECT-Ub intermediates [228].
Catalytically active HECT domains varied in their ability to stimulate PPxYdependent particle release. Notably, chimeric HECT ligases exhibited similar patterns of
stimulation of PPxY-dependent VLP production by lysine-free and lysine-containing
PFV Gag (data not shown). We found this variability to correlate directly with the levels
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of HECT ligase autoubiquitination, but not with their ability to ubiquitinate a Gag
substrate that contains several lysines in close proximity to a PPxY motif. This is in
agreement with our finding that direct Gag ubiquitination is dispensable for PPxYdependent budding and consistent with a model in which HECT ligases promote VLP
release by ubiquitinating trans-acting factors. However, it is unclear whether
ubiquitination of HECT ligases, specifically, is critical for Class E pathway engagement,
or if autoubiquitinated ligases simply represent the one of the ubiquitinated protein
species at virion assembly sites.
The C2 and WW domains appear to be dispensable for HECT ligase-mediated
VLP release. Catalytically active HECT domains fused to the Tsg101 UEV domain
stimulated PSAP-dependent budding, while the corresponding catalytically inactive
mutants suppressed particle production. Thus, as long as they are enzymatically intact
and can be recruited to sites of virion assembly, HECT domains encode all of the
activities necessary for the promotion of VLP release. It seems unlikely, therefore, that
HECT ligases engage the Class E pathway by recruiting substrates via their WW or C2
domains.
The autoubiquitination activity of HECT E3 ligases has been linked to their
ability to monoubiquitinate substrates by a mechanism called coupled ubiquitination
[288]. Conventional HECT ligase substrate recognition occurs via relatively stable
interactions between the WW domains of the ligase and the PPxY motifs in the substrate.
In contrast, proteins that contain ubiquitin interacting motifs (UIMs), sometimes referred
to as “ubiquitin receptors”, can transiently associate with autoubiquitinated HECT ligases
and become monoubiquitinated in the absence of WW-PPxY interactions. Thus, it is
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conceivable for autoubiquitinated HECT ligases to promote VLP release by recruiting
UIM-containing VPS proteins to sites of virion assembly. Interestingly, the catalytically
active WWP2 HECT ligase, which does not exhibit a significant amount of
autoubiquitination, cannot ubiquitinate UIM-containing substrates, presumably because it
cannot efficiently recruit them [288]. Similarly, the weak autoubiquitination of our
chimeric WWP1/WWP2 HECT ligase could account for its inability to engage the Class
E machinery and thereby stimulate PPxY dependent PFV Gag budding in our
experimental system.
Remarkably, direct fusion of a single ubiquitin moiety to the C-terminus of PFV
Gag potently stimulated late domain-dependent and -independent budding. Direct
ubiquitin fusion to RSV Gag has previously been shown to rescue the late budding defect
in cells treated with proteasome inhibitors [104]. However, ubiquitin fusion cannot
compensate for the deletion of the RSV late domain or further stimulate wild-type RSV
Gag budding. Additionally, ubiquitin fusion rescues budding of EIAV Gag with an
inactive late domain but has no effect on late domain-dependent EIAV Gag budding
[258]. To our knowledge, our study is the first to demonstrate strong enhancement of late
domain-dependent VLP production by direct fusion of ubiquitin to Gag. This could be
attributed to inherently inefficient cofactor recruitment by the natural PFV late domain.
Ubiquitin may serve as an additional docking site for VPS factors, thereby synergizing
with the late domain to optimally utilize the available cellular Class E machinery.
Although we have not visually ascertained that the PFV Gag-ubiquitin fusion
protein can assemble into bona fide VLPs, ubiquitin-dependent particle release occurred
by a regulated mechanism. The Ile44 hydrophobic patch of ubiquitin, which is an
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important interaction surface for various ubiquitin-binding domains (e.g. UIM, UBD,
GLUE, etc.), was essential for the rescue of late domain-deficient Gag budding.
Additionally, ablation of Class E machinery function by overexpression of catalytically
inactive Vps4 suppressed ubiquitin-dependent particle production. Moreover, particles
formed by ubiquitin-fused EIAV Gag are morphologically similar to those assembled by
wild-type EIAV Gag [258].
Since ubiquitin-binding domains have a very low affinity for individual ubiquitin
molecules and thus primarily mediate transient interactions, efficient retention of UIMencoding Class E factors in the vicinity of Gag assembly sites would require an
abundance of UIM docking sites. Indeed, the five ubiquitin binding domains (two VHSs
and three UIMs) of ESCRT-0 have been shown to cooperatively bind polyubiquitin, but
not mono- or diubiquitin, with high avidity, requiring at least three functional ubiquitin
binding sites to support detectable levels of cargo sorting [161]. In agreement with this
model, direct ubiquitin fusion to PFV Gag could effectively bypass the need for late
domain-dependent recruitment of Class E factors only when a large fraction (~50%) of
Gag molecules carried ubiquitin. This equates to about 1000 or more ubiquitin monomers
per virion, assuming that ubiquitin-fused and unfused Gag molecules are incorporated
into assembling particles with equivalent efficiency.
As with conventional late domain-dependent particle production, the Class E VPS
pathway must be intact to support ubiquitin-dependent budding. Ablation of individual
segments of the pathway resulted in partial inhibition of ubiquitin- and PPxY-dependent
particle release. However, simultaneous depletion of Tsg101 and ALIX caused a stronger
suppression of particle release than depletion of either factor alone, suggesting that they
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may serve redundant roles in ubiquitin-dependent budding. Multiple ubiquitin-interacting
domains within ESCRT-0, ESCRT-I, ESCRT-II and associated factors could, in
principle, provide parallel mechanisms for ubiquitin-dependent engagement of the VPS
machinery. Indeed, this was recently demonstrated in yeast, where simultaneous
disruption of ubiquitin binding by ESCRT-I, ESCRT-II and Bro1 (ALIX homolog) and
the association between ESCRT-I and ESCRT-0 was necessary to completely block the
sorting of ubiquitinated cargo to the lysosome [154]. This suggests that all entry points
into the Class E pathway must be simultaneously ablated to completely inhibit ubiquitinor HECT ligase-dependent budding.

Future directions
Although we have not performed a detailed analysis of the specific types of
ubiquitin modifications generated by our chimeric HECT ligases, we noticed variability
in the distribution of synthesized chain lengths. For instance, WWP1/Itch preferentially
formed longer polyubiquitin chains, whereas WWP1/Bul2 and WWP1/Rsp5 formed
relatively high proportions of mono- or diubiquitinated products. These differences could
contribute to the relative efficiency with which HECT ligases stimulate virus particle
production. Moreover, the ubiquitin chains synthesized by various ligases may differ in
the types of lysine linkages they contain. Full-length Rsp5, Nedd4, and Itch ligases have
been shown to form Lys63-linked chains more efficiently than other types of
polyubiquitin chains [289], but the linkage specificity of other Nedd4 family members
has not been reported. The multivalent ESCRT-0 complex binds Lys63-linked ubiquitin
chains with greater affinity than Lys48-linked or linear head-to-tail ubiquitin chains
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[161]. Thus, chain length and linkage specificity could influence the ability of ubiquitin
ligases to engage the Class E machinery.
Several aspects of HECT domain biochemistry are amenable to experimental
manipulation. We can force certain types of ubiquitin chain linkages to be
overrepresented or excluded in ubiquitin transfer or VLP production assays by
overexpression of ubiquitin mutants that either contain or lack specific lysine residues.
Thus, we could assess the chain type specificity of our chimeric HECT ligases and
determine whether certain ubiquitin linkage types are preferentially recognized by the
VPS machinery to promote virus particle release. The specificity for Lys48 or Lys63-type
linkages is thought to be determined by a 60-residue segment at the HECT domain Cterminus [289]. We could thus, in principle, assess the relative importance of ubiquitin
linkages in viral budding by swapping this domain between HECT ligases with different
linkage specificities. Since all of the Nedd4-like HECT domains tested thus far
preferentially generate Lys63-linked ubiquitin chains, it would be interesting to test the
ability of the E6AP HECT domain, which preferentially forms Lys48-linked chains
[289], to stimulate PPxY-dependent VLP release.
HECT domains possess additional mechanisms that regulate their enzymatic
activity. For example, the highly conserved α1 helix suppresses the overall catalytic
activity of HECT domains and preferentially inhibits their autoubiquitination [290].
Disruption of interactions between the α1 helix and the HECT domain N-lobe may
increase HECT ligase promiscuity and have interesting implications for their ability to
promote VLP release. Additionally, the N-lobe of HECT domains contains a noncovalent
ubiquitin binding site, which enables polyubiquitination by some HECT ligases and
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limits the length of ubiquitin chains produced by others [213,214]. Thus, it would be
interesting to test the effect of ubiquitin binding site disruption on the ubiquitination and
particle release stimulation patterns of our chimeric HECT ligases.
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